Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Neuroactive ligand-receptor interaction (mmu04080)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1810009J
06Rik
KLA  ATP  ATP+KLA
 NM_023707 RIKEN cDNA 1810009J06 gene (1810009J06Rik), mRNA [NM_023707] KLA .94 1.09 1.01 .98 1.05 .99 1.19
ATP .96 .90 .96 1.04 .99 1.07 1.05
KLA/ATP 1.02 .98 1.01 1.09 1.08 1.06 1.01
2210010C
04Rik
KLA  ATP  ATP+KLA
 NM_023333 RIKEN cDNA 2210010C04 gene (2210010C04Rik), mRNA [NM_023333] KLA 1.36 1.41 1.44 1.22 1.24 1.13 1.10
ATP 1.02 .98 1.05 .96 1.01 1.02 1.06
KLA/ATP 1.35 1.18 1.33 1.15 1.02 1.06 1.09
Adcyap1
KLA  ATP  ATP+KLA
 NM_009625 adenylate cyclase activating polypeptide 1 (Adcyap1), mRNA [NM_009625] KLA 1.00 1.02 .98 .99 1.01 .99 .90
ATP 1.05 1.00 .93 .94 .98 .96 .96
KLA/ATP .99 .97 .99 .98 .92 .90 .94
Adcyap1r
1
KLA  ATP  ATP+KLA
 NM_007407 adenylate cyclase activating polypeptide 1 receptor 1 (Adcyap1r1), transcript variant 1, mRNA [NM_007407] KLA 1.03 1.02 .99 1.03 1.02 1.02 1.05
ATP 1.03 1.01 1.14 1.01 .99 1.02 1.01
KLA/ATP .97 .99 1.03 1.08 1.04 1.04 .98
Adora1
KLA  ATP  ATP+KLA
 NM_001008533 adenosine A1 receptor (Adora1), transcript variant 1, mRNA [NM_001008533] KLA 1.01 1.03 .94 1.00 1.01 1.11 1.13
ATP .99 1.02 1.06 1.05 1.07 1.02 1.16
KLA/ATP 1.05 .99 1.02 1.04 1.05 1.11 1.09
Adora2a
KLA  ATP  ATP+KLA
 NM_009630 adenosine A2a receptor (Adora2a), mRNA [NM_009630] KLA 9.23 9.88 9.08 9.21 9.36 7.45 8.23
ATP 1.09 1.01 1.36 2.05 4.26 8.29 1.91
KLA/ATP 9.17 11.00 9.06 9.28 10.88 11.46 9.73
Adora2b
KLA  ATP  ATP+KLA
 NM_007413 adenosine A2b receptor (Adora2b), mRNA [NM_007413] KLA 2.50 3.09 4.71 7.11 7.38 4.18 3.17
ATP .98 1.02 1.16 4.52 8.81 7.95 2.66
KLA/ATP 2.56 3.38 4.49 5.78 7.34 7.41 6.23
Adora3
KLA  ATP  ATP+KLA
 AK013534 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:2900016D13 product:A3 ADENOSINE RECEPTOR, full insert sequence [AK013534] KLA 1.66 1.76 2.92 3.13 3.41 2.11 1.40
ATP 1.16 1.07 1.11 1.04 1.05 1.33 1.56
KLA/ATP 1.91 1.85 1.84 1.66 1.33 1.36 1.34
Adora3
KLA  ATP  ATP+KLA
 NM_009631 adenosine A3 receptor (Adora3), transcript variant 1, mRNA [NM_009631] KLA 1.54 1.63 2.45 2.54 2.96 2.32 1.49
ATP 1.04 1.02 1.15 1.19 1.07 1.52 2.16
KLA/ATP 1.70 1.64 1.59 1.55 1.28 1.96 2.06
Adora3
KLA  ATP  ATP+KLA
 NM_027025 adenosine A3 receptor (Adora3), transcript variant 2, mRNA [NM_027025] KLA 1.00 1.05 1.10 1.06 1.08 1.10 1.00
ATP 1.01 1.08 1.04 1.09 .98 1.07 1.17
KLA/ATP 1.12 1.02 1.00 1.00 .99 1.15 1.10
Adra1a
KLA  ATP  ATP+KLA
 NM_013461 adrenergic receptor, alpha 1a (Adra1a), mRNA [NM_013461] KLA .78 .74 .75 .85 .96 1.37 2.70
ATP 1.05 1.14 .97 .97 1.69 1.06 2.56
KLA/ATP .76 .75 .83 .84 1.51 1.34 4.08
Adra1b
KLA  ATP  ATP+KLA
 NM_007416 adrenergic receptor, alpha 1b (Adra1b), mRNA [NM_007416] KLA 1.04 .99 .98 1.02 .99 1.00 1.01
ATP 1.00 .99 .98 1.01 1.06 1.01 1.05
KLA/ATP .99 .97 1.03 1.03 1.00 .97 1.08
Adra1d
KLA  ATP  ATP+KLA
 NM_013460 adrenergic receptor, alpha 1d (Adra1d), mRNA [NM_013460] KLA 1.13 1.12 1.21 1.25 1.30 1.34 1.27
ATP 1.02 .99 1.16 1.08 1.13 1.11 1.06
KLA/ATP 1.15 1.10 1.20 1.14 1.24 1.16 1.13
Adra2a
KLA  ATP  ATP+KLA
 NM_007417 adrenergic receptor, alpha 2a (Adra2a), mRNA [NM_007417] KLA 1.00 .92 .97 .98 .93 .97 .95
ATP 1.00 .98 1.07 1.36 1.19 1.23 1.06
KLA/ATP .94 .98 1.01 1.20 1.25 1.16 1.03
Adra2b
KLA  ATP  ATP+KLA
 NM_009633 adrenergic receptor, alpha 2b (Adra2b), mRNA [NM_009633] KLA .94 1.00 1.08 1.00 1.03 .94 1.05
ATP .95 1.00 1.01 .98 .94 1.11 1.10
KLA/ATP .99 1.14 1.10 1.05 1.01 1.09 1.10
Adra2c
KLA  ATP  ATP+KLA
 NM_007418 adrenergic receptor, alpha 2c (Adra2c), mRNA [NM_007418] KLA 1.04 .99 .96 1.08 .95 1.01 .99
ATP 1.02 .99 .98 1.03 1.01 .97 .91
KLA/ATP 1.05 .98 .97 .96 .95 1.00 1.07
Adrb1
KLA  ATP  ATP+KLA
 NM_007419 adrenergic receptor, beta 1 (Adrb1), mRNA [NM_007419] KLA .88 .86 .88 .86 .87 .87 .87
ATP .97 .97 .95 .89 .89 .90 .87
KLA/ATP .90 .88 .91 .84 .91 .79 .82
Adrb2
KLA  ATP  ATP+KLA
 NM_007420 adrenergic receptor, beta 2 (Adrb2), mRNA [NM_007420] KLA .28 .26 .32 .31 .34 .31 .29
ATP 2.09 2.43 2.74 1.72 .96 .63 .29
KLA/ATP .28 .29 .52 .69 .65 .35 .23
Agrp
KLA  ATP  ATP+KLA
 NM_007427 agouti related protein (Agrp), mRNA [NM_007427] KLA 1.03 .96 1.01 .99 1.02 .97 1.01
ATP 1.00 1.03 .99 .99 .97 .97 .94
KLA/ATP .94 .98 1.00 .94 .94 .93 .97
Agtr1a
KLA  ATP  ATP+KLA
 NM_177322 angiotensin II receptor, type 1a (Agtr1a), mRNA [NM_177322] KLA 1.04 1.00 1.00 1.03 1.03 .95 1.00
ATP .98 .99 1.00 1.00 .95 1.05 1.06
KLA/ATP 1.00 .97 1.03 .97 .99 .96 .98
Agtr1b
KLA  ATP  ATP+KLA
 NM_175086 angiotensin II receptor, type 1b (Agtr1b), mRNA [NM_175086] KLA 1.02 .94 1.04 1.01 1.01 1.00 .95
ATP .97 1.01 1.03 .95 .98 1.09 1.02
KLA/ATP .94 .99 .99 .97 .99 .95 1.12
Agtr2
KLA  ATP  ATP+KLA
 NM_007429 angiotensin II receptor, type 2 (Agtr2), mRNA [NM_007429] KLA .99 .93 1.00 .98 .98 1.03 .96
ATP 1.03 1.10 1.02 1.01 .91 1.03 1.01
KLA/ATP .93 .95 1.01 .99 1.00 .95 .99
Agtrl1
KLA  ATP  ATP+KLA
 NM_011784 angiotensin receptor-like 1 (Agtrl1), mRNA [NM_011784] KLA 1.01 1.06 1.08 1.16 1.14 1.13 1.02
ATP .98 1.13 1.08 .93 1.00 1.10 1.13
KLA/ATP .98 .97 1.22 1.09 1.04 1.15 1.09
AK082687
KLA  ATP  ATP+KLA
 AK082687 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230086D05 product:unclassifiable, full insert sequence [AK082687] KLA 1.00 .95 1.04 .95 1.01 1.01 1.14
ATP 1.00 .96 1.03 1.05 .92 1.02 .89
KLA/ATP 1.01 1.09 1.04 1.03 1.05 1.01 1.02
Apln
KLA  ATP  ATP+KLA
 NM_013912 apelin (Apln), mRNA [NM_013912] KLA 1.11 1.12 1.19 1.18 1.27 1.26 1.19
ATP 1.04 1.00 1.08 1.03 .98 .93 1.03
KLA/ATP 1.11 1.13 1.17 1.14 1.08 .99 1.13
Avp
KLA  ATP  ATP+KLA
 NM_009732 arginine vasopressin (Avp), mRNA [NM_009732] KLA .98 .99 1.04 1.02 1.03 1.09 1.05
ATP 1.02 1.06 1.03 .99 1.01 1.01 1.08
KLA/ATP 1.00 1.02 1.10 1.01 .99 1.02 1.02
Avpr1a
KLA  ATP  ATP+KLA
 NM_016847 arginine vasopressin receptor 1A (Avpr1a), mRNA [NM_016847] KLA 1.00 1.07 .95 .99 1.01 1.01 1.00
ATP .99 .94 1.01 1.08 1.01 1.06 .99
KLA/ATP 1.10 .98 1.04 1.00 .99 1.05 1.00
Avpr1b
KLA  ATP  ATP+KLA
 NM_011924 arginine vasopressin receptor 1B (Avpr1b), mRNA [NM_011924] KLA 1.01 .93 .97 1.03 1.00 .97 1.01
ATP .99 1.02 1.05 1.03 1.01 1.04 1.06
KLA/ATP .93 1.00 .97 .97 .92 .96 1.04
Avpr2
KLA  ATP  ATP+KLA
 NM_019404 arginine vasopressin receptor 2 (Avpr2), mRNA [NM_019404] KLA .98 1.00 .99 1.01 .98 1.05 .95
ATP .99 1.00 1.02 1.01 1.01 1.05 1.01
KLA/ATP 1.00 .98 1.02 .98 .98 1.01 1.02
Bdkrb1
KLA  ATP  ATP+KLA
 NM_007539 bradykinin receptor, beta 1 (Bdkrb1), mRNA [NM_007539] KLA 1.60 1.44 1.47 1.36 1.29 1.38 1.04
ATP 1.05 .99 1.17 1.12 1.15 1.16 .95
KLA/ATP 1.51 1.59 1.94 1.30 1.22 1.23 1.20
Bdkrb2
KLA  ATP  ATP+KLA
 NM_009747 bradykinin receptor, beta 2 (Bdkrb2), mRNA [NM_009747] KLA .97 .96 1.01 1.09 1.01 1.00 1.08
ATP 1.07 .98 1.04 1.01 1.05 1.00 1.08
KLA/ATP 1.02 1.05 1.04 1.01 1.03 1.04 .98
Brs3
KLA  ATP  ATP+KLA
 NM_009766 bombesin-like receptor 3 (Brs3), mRNA [NM_009766] KLA 1.01 1.02 1.04 .99 1.04 .99 .98
ATP .98 1.08 .99 .94 .96 1.04 .96
KLA/ATP .94 .96 1.02 .99 .95 .95 1.06
C3ar1
KLA  ATP  ATP+KLA
 NM_009779 complement component 3a receptor 1 (C3ar1), mRNA [NM_009779] KLA .93 1.01 1.03 1.20 1.34 1.60 1.59
ATP 1.03 1.13 .81 .99 .72 .48 1.44
KLA/ATP 1.06 1.02 .77 .99 .81 .85 1.20
C5ar1
KLA  ATP  ATP+KLA
 NM_007577 complement component 5a receptor 1 (C5ar1), mRNA [NM_007577] KLA 1.10 1.18 1.09 .81 .64 .49 .83
ATP 1.07 1.30 1.02 2.07 .92 .48 1.75
KLA/ATP 1.24 1.32 .83 1.58 .69 .46 .85
Calcr
KLA  ATP  ATP+KLA
 NM_007588 calcitonin receptor (Calcr), transcript variant a, mRNA [NM_007588] KLA .98 1.01 1.05 1.03 1.06 1.12 1.06
ATP .99 .97 1.01 1.05 1.00 1.00 1.02
KLA/ATP 1.02 1.02 .95 1.00 1.02 1.04 1.02
Calcrl
KLA  ATP  ATP+KLA
 NM_018782 calcitonin receptor-like (Calcrl), mRNA [NM_018782] KLA 3.33 3.29 2.57 2.69 1.56 .90 1.22
ATP .93 .86 .80 .77 .85 1.39 .79
KLA/ATP 2.95 2.86 1.96 1.75 1.26 .78 .79
Cck
KLA  ATP  ATP+KLA
 NM_031161 cholecystokinin (Cck), mRNA [NM_031161] KLA .96 1.11 .98 .99 .91 1.00 1.10
ATP 1.00 1.00 1.03 1.13 1.02 1.17 2.72
KLA/ATP 1.08 1.00 .91 1.06 1.04 1.07 1.38
Cckar
KLA  ATP  ATP+KLA
 NM_009827 cholecystokinin A receptor (Cckar), mRNA [NM_009827] KLA 1.00 .97 1.05 1.07 .99 1.08 1.03
ATP 1.08 1.00 1.10 1.07 .94 1.00 .98
KLA/ATP .99 .98 .99 1.04 1.00 1.04 1.02
Cckbr
KLA  ATP  ATP+KLA
 NM_007627 cholecystokinin B receptor (Cckbr), mRNA [NM_007627] KLA 1.03 1.01 1.07 1.05 1.01 1.11 1.03
ATP .94 1.04 1.04 .97 1.01 1.05 1.02
KLA/ATP 1.03 .99 1.03 1.02 1.01 1.06 1.04
Cga
KLA  ATP  ATP+KLA
 NM_009889 glycoprotein hormones, alpha subunit (Cga), mRNA [NM_009889] KLA .98 .95 .95 1.01 1.01 .95 1.01
ATP .96 .89 .84 .90 1.03 .88 .98
KLA/ATP .99 .98 .83 .89 .98 .91 .86
Chrm1
KLA  ATP  ATP+KLA
 NM_001112697 cholinergic receptor, muscarinic 1, CNS (Chrm1), transcript variant 1, mRNA [NM_001112697] KLA 1.12 .99 .97 1.09 .92 .91 .97
ATP .95 1.06 1.01 1.06 1.05 1.06 .99
KLA/ATP 1.00 .99 1.02 1.00 1.05 .95 1.01
Chrm2
KLA  ATP  ATP+KLA
 NM_203491 cholinergic receptor, muscarinic 2, cardiac (Chrm2), mRNA [NM_203491] KLA 1.03 1.05 .98 1.02 1.04 1.06 1.05
ATP 1.09 .94 1.08 1.06 .98 1.04 .97
KLA/ATP 1.01 1.05 .97 1.01 .98 1.07 .99
Chrm3
KLA  ATP  ATP+KLA
 AK051841 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230008K23 product:unclassifiable, full insert sequence. [AK051841] KLA .92 .97 1.02 1.05 .96 .99 1.00
ATP 1.00 .99 .99 .95 1.05 1.02 1.01
KLA/ATP .91 .98 1.06 1.07 .94 1.00 .94
Chrm3
KLA  ATP  ATP+KLA
 NM_033269 cholinergic receptor, muscarinic 3, cardiac (Chrm3), mRNA [NM_033269] KLA .91 .99 .98 .93 1.08 1.01 1.06
ATP .97 1.05 1.03 .95 .99 1.01 1.10
KLA/ATP 1.05 1.09 .99 1.00 .98 1.03 1.00
Chrm4
KLA  ATP  ATP+KLA
 NM_007699 cholinergic receptor, muscarinic 4 (Chrm4), mRNA [NM_007699] KLA .95 1.01 .97 .97 .96 1.07 1.04
ATP 1.08 1.01 1.04 1.08 1.01 .99 .98
KLA/ATP 1.01 1.04 1.04 .99 .99 .96 .99
Chrm5
KLA  ATP  ATP+KLA
 NM_205783 cholinergic receptor, muscarinic 5 (Chrm5), mRNA [NM_205783] KLA .98 1.02 .96 .98 1.03 1.02 1.02
ATP 1.02 .96 .96 1.15 1.00 1.06 1.04
KLA/ATP 1.02 .90 .95 1.05 1.04 1.05 .95
Chrna1
KLA  ATP  ATP+KLA
 NM_007389 cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) (Chrna1), mRNA [NM_007389] KLA .98 1.00 1.04 .97 .99 .98 1.02
ATP .95 .97 1.00 1.01 1.01 1.04 1.11
KLA/ATP .96 .98 1.00 1.01 .97 .99 .97
Chrna10
KLA  ATP  ATP+KLA
 NM_001081424 cholinergic receptor, nicotinic, alpha polypeptide 10 (Chrna10), mRNA [NM_001081424] KLA .95 1.04 1.03 1.04 .94 .99 .97
ATP 1.03 1.00 1.03 1.03 1.04 .97 1.02
KLA/ATP 1.03 1.03 1.07 1.01 .96 1.01 1.03
Chrna2
KLA  ATP  ATP+KLA
 NM_144803 cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal) (Chrna2), mRNA [NM_144803] KLA 1.01 .97 .96 1.08 .99 .97 1.12
ATP 1.03 1.00 .92 1.01 .99 .92 1.07
KLA/ATP 1.06 .99 1.00 1.04 .98 .93 .88
Chrna3
KLA  ATP  ATP+KLA
 NM_145129 cholinergic receptor, nicotinic, alpha polypeptide 3 (Chrna3), mRNA [NM_145129] KLA 1.03 1.04 1.00 1.03 1.08 1.04 .99
ATP .98 .95 .97 1.02 1.04 1.02 .99
KLA/ATP .99 .99 1.02 1.04 1.07 .99 1.02
Chrna4
KLA  ATP  ATP+KLA
 NM_015730 cholinergic receptor, nicotinic, alpha polypeptide 4 (Chrna4), mRNA [NM_015730] KLA .99 .96 1.01 1.01 1.00 .98 .96
ATP 1.02 .98 .97 1.04 .94 .96 .94
KLA/ATP .97 .99 1.00 .98 1.00 .98 .98
Chrna5
KLA  ATP  ATP+KLA
 NM_176844 cholinergic receptor, nicotinic, alpha polypeptide 5 (Chrna5), mRNA [NM_176844] KLA 1.67 2.23 3.03 2.92 2.92 1.70 1.09
ATP 1.03 1.05 1.14 1.03 .96 1.06 1.04
KLA/ATP 1.91 2.14 1.97 2.05 1.46 1.48 1.18
Chrna6
KLA  ATP  ATP+KLA
 NM_021369 cholinergic receptor, nicotinic, alpha polypeptide 6 (Chrna6), mRNA [NM_021369] KLA 1.05 .98 1.00 .93 1.05 .98 .96
ATP .99 .93 .98 .99 .92 .95 1.01
KLA/ATP 1.00 1.00 1.02 .93 .96 .94 1.05
Chrna7
KLA  ATP  ATP+KLA
 NM_007390 cholinergic receptor, nicotinic, alpha polypeptide 7 (Chrna7), mRNA [NM_007390] KLA 1.01 .99 1.04 .96 .99 .99 1.01
ATP .99 .97 1.00 1.00 .99 1.04 1.00
KLA/ATP .98 1.02 1.04 .99 .95 .96 1.07
Chrna9
KLA  ATP  ATP+KLA
 NM_001081104 cholinergic receptor, nicotinic, alpha polypeptide 9 (Chrna9), mRNA [NM_001081104] KLA 1.06 1.07 1.05 1.01 .99 1.01 .94
ATP .97 1.01 1.05 1.03 1.00 1.08 .99
KLA/ATP 1.01 1.04 1.15 1.02 1.08 1.15 1.05
Chrnb1
KLA  ATP  ATP+KLA
 NM_009601 cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) (Chrnb1), mRNA [NM_009601] KLA .90 .97 .96 1.00 .95 .91 .98
ATP 1.03 1.00 .91 1.02 .96 .98 .93
KLA/ATP 1.00 .96 .97 .92 .94 .93 .90
Chrnb2
KLA  ATP  ATP+KLA
 NM_009602 cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) (Chrnb2), mRNA [NM_009602] KLA .89 .85 .89 .88 .78 .97 .93
ATP 1.03 .99 1.36 2.35 1.30 .97 .86
KLA/ATP .86 .91 .80 1.23 1.14 1.03 1.02
Chrnb3
KLA  ATP  ATP+KLA
 NM_027454 cholinergic receptor, nicotinic, beta polypeptide 3 (Chrnb3), transcript variant 2, mRNA [NM_027454] KLA .95 1.00 1.02 1.02 1.05 .98 1.11
ATP .98 .95 1.04 1.04 1.07 .98 1.00
KLA/ATP .92 1.09 .92 1.05 .91 1.07 .95
Chrnb3
KLA  ATP  ATP+KLA
 NM_173212 cholinergic receptor, nicotinic, beta polypeptide 3 (Chrnb3), transcript variant 1, mRNA [NM_173212] KLA .98 1.00 .99 .95 1.01 .99 .98
ATP 1.01 1.00 .98 .98 1.02 .96 1.06
KLA/ATP .99 1.00 1.01 1.04 1.01 1.02 1.13
Chrnb4
KLA  ATP  ATP+KLA
 NM_148944 cholinergic receptor, nicotinic, beta polypeptide 4 (Chrnb4), mRNA [NM_148944] KLA 1.01 1.04 .94 1.00 1.01 .96 .98
ATP .97 1.00 .98 .98 1.01 1.05 1.00
KLA/ATP .95 .99 1.06 .97 .98 .99 1.04
Chrnd
KLA  ATP  ATP+KLA
 NM_021600 cholinergic receptor, nicotinic, delta polypeptide (Chrnd), mRNA [NM_021600] KLA 1.02 .92 1.09 1.02 .97 1.00 1.08
ATP .98 1.06 .96 1.02 1.05 1.13 1.02
KLA/ATP 1.02 1.02 1.02 .96 1.03 1.07 1.02
Chrne
KLA  ATP  ATP+KLA
 NM_009603 cholinergic receptor, nicotinic, epsilon polypeptide (Chrne), mRNA [NM_009603] KLA 1.29 1.23 1.31 1.42 1.21 1.35 1.06
ATP 1.00 1.02 1.28 1.35 1.36 1.39 1.18
KLA/ATP 1.31 1.43 1.65 1.55 1.62 1.87 1.51
Chrng
KLA  ATP  ATP+KLA
 NM_009604 cholinergic receptor, nicotinic, gamma polypeptide (Chrng), mRNA [NM_009604] KLA 1.00 1.02 1.02 1.04 1.04 1.02 1.06
ATP 1.00 1.01 1.00 1.02 1.00 .99 1.00
KLA/ATP 1.04 .99 1.01 1.01 1.03 1.03 1.02
Cnr1
KLA  ATP  ATP+KLA
 NM_007726 cannabinoid receptor 1 (brain) (Cnr1), mRNA [NM_007726] KLA .97 1.05 1.03 .96 .98 1.01 .92
ATP 1.02 1.05 1.01 .92 1.06 1.04 .93
KLA/ATP 1.00 .99 .96 .96 1.00 .95 .99
Cnr2
KLA  ATP  ATP+KLA
 NM_009924 cannabinoid receptor 2 (macrophage) (Cnr2), mRNA [NM_009924] KLA .16 .16 .16 .20 .17 .25 .31
ATP .92 1.03 .95 .81 .33 .18 1.26
KLA/ATP .15 .15 .20 .22 .21 .21 .44
Copa
KLA  ATP  ATP+KLA
 NM_009938 coatomer protein complex subunit alpha (Copa), mRNA [NM_009938] KLA 1.13 1.17 1.30 1.14 1.15 1.15 1.10
ATP 1.03 1.09 .98 .97 .93 .88 1.02
KLA/ATP 1.30 1.22 1.01 1.05 .88 .92 .94
Cort
KLA  ATP  ATP+KLA
 NM_007745 cortistatin (Cort), mRNA [NM_007745] KLA 1.02 1.05 1.01 1.05 1.08 1.03 .99
ATP 1.05 1.03 1.04 1.06 .99 .98 .95
KLA/ATP 1.11 1.07 1.16 1.08 1.04 1.06 .97
Crhr1
KLA  ATP  ATP+KLA
 NM_007762 corticotropin releasing hormone receptor 1 (Crhr1), mRNA [NM_007762] KLA 1.00 1.05 1.06 1.05 1.06 1.06 1.05
ATP 1.04 .97 1.03 1.06 1.09 1.07 1.03
KLA/ATP 1.08 1.10 1.05 1.11 1.10 1.05 1.13
Crhr2
KLA  ATP  ATP+KLA
 NM_009953 corticotropin releasing hormone receptor 2 (Crhr2), mRNA [NM_009953] KLA 1.02 1.08 1.06 1.15 1.12 1.16 1.16
ATP 1.00 .99 1.22 1.12 1.22 1.22 1.22
KLA/ATP .99 1.08 1.21 1.19 1.32 1.25 1.26
Ctsg
KLA  ATP  ATP+KLA
 NM_007800 cathepsin G (Ctsg), mRNA [NM_007800] KLA 1.15 1.23 1.36 1.24 1.14 1.09 1.22
ATP .97 1.04 1.19 1.22 1.30 1.19 .98
KLA/ATP 1.19 1.30 1.52 1.58 1.34 1.23 1.07
Cysltr1
KLA  ATP  ATP+KLA
 NM_021476 cysteinyl leukotriene receptor 1 (Cysltr1), mRNA [NM_021476] KLA 1.11 1.17 1.25 1.45 1.45 1.36 1.16
ATP .93 .87 1.03 .83 .42 .35 .71
KLA/ATP 1.01 1.03 1.13 .95 .59 .40 .61
Cysltr2
KLA  ATP  ATP+KLA
 NM_133720 cysteinyl leukotriene receptor 2 (Cysltr2), mRNA [NM_133720] KLA 3.09 2.91 3.56 3.38 2.86 3.71 3.63
ATP 1.00 .91 1.13 .96 .77 1.04 2.02
KLA/ATP 3.07 3.48 3.37 2.52 1.66 1.37 4.59
Drd1a
KLA  ATP  ATP+KLA
 NM_010076 dopamine receptor D1A (Drd1a), mRNA [NM_010076] KLA .94 .99 1.02 .98 .98 .99 1.06
ATP 1.07 1.03 1.01 1.08 1.08 .96 1.04
KLA/ATP 1.04 1.00 1.01 1.06 1.08 1.06 1.09
Drd2
KLA  ATP  ATP+KLA
 NM_010077 dopamine receptor 2 (Drd2), mRNA [NM_010077] KLA 1.02 .98 1.03 1.09 1.07 .97 1.09
ATP 1.07 1.00 .98 1.11 1.03 1.01 1.03
KLA/ATP 1.13 1.12 1.09 1.08 1.02 1.01 1.11
Drd2
KLA  ATP  ATP+KLA
 X55674 gb|M.musculus mRNA for D2A dopamine receptor [X55674] KLA .95 1.00 1.06 .98 .97 1.02 1.02
ATP .97 .97 .99 .97 .99 .97 1.01
KLA/ATP .97 1.03 .91 .90 .95 .89 1.00
Drd3
KLA  ATP  ATP+KLA
 NM_007877 dopamine receptor 3 (Drd3), mRNA [NM_007877] KLA 1.01 1.05 .99 1.00 1.04 1.02 1.10
ATP 1.01 .92 1.08 1.08 .98 .89 .97
KLA/ATP .95 1.05 .87 .95 1.09 1.06 .97
Drd4
KLA  ATP  ATP+KLA
 BC051421 dopamine receptor 4, mRNA (cDNA clone MGC:58931 IMAGE:6492837), complete cds [BC051421] KLA .98 1.04 1.01 .99 .99 1.02 .98
ATP 1.00 1.00 1.00 1.03 1.01 1.03 1.04
KLA/ATP 1.00 1.00 1.04 1.01 1.01 1.01 1.03
Drd4
KLA  ATP  ATP+KLA
 NM_007878 dopamine receptor 4 (Drd4), mRNA [NM_007878] KLA 1.05 1.04 1.01 .98 1.04 1.14 1.09
ATP 1.03 .99 .91 .92 1.05 1.00 .99
KLA/ATP 1.03 1.04 .97 1.00 1.03 .99 1.02
Drd5
KLA  ATP  ATP+KLA
 NM_013503 dopamine receptor 5 (Drd5), mRNA [NM_013503] KLA 1.00 .99 .99 .93 .97 1.04 1.03
ATP .99 1.00 1.00 1.01 1.01 1.02 1.00
KLA/ATP 1.05 .95 .98 1.00 .98 1.01 1.01
Edg1
KLA  ATP  ATP+KLA
 NM_007901 endothelial differentiation sphingolipid G-protein-coupled receptor 1 (Edg1), mRNA [NM_007901] KLA .08 .07 .09 .11 .12 .21 .35
ATP 1.11 1.20 1.14 1.02 .80 .72 .89
KLA/ATP .08 .08 .12 .16 .23 .41 .64
Edg3
KLA  ATP  ATP+KLA
 NM_010101 endothelial differentiation, sphingolipid G-protein-coupled receptor, 3 (Edg3), mRNA [NM_010101] KLA .97 .99 .96 .98 .96 .99 .95
ATP .98 1.04 1.09 1.08 1.06 1.02 1.05
KLA/ATP .92 .97 1.06 1.12 1.14 .98 1.07
Edg5
KLA  ATP  ATP+KLA
 L20334 gb|Mouse EDG-like receptor mRNA, partial cds. [L20334] KLA 1.21 1.20 1.44 1.30 1.64 2.62 1.88
ATP .99 1.22 .88 .84 1.01 .99 1.42
KLA/ATP 1.23 1.29 .92 1.02 1.41 1.93 2.45
Edg5
KLA  ATP  ATP+KLA
 NM_010333 endothelial differentiation, sphingolipid G-protein-coupled receptor, 5 (Edg5), mRNA [NM_010333] KLA 1.14 1.04 1.23 1.22 1.71 2.22 1.65
ATP 1.06 1.18 .80 .66 1.04 .86 1.44
KLA/ATP 1.16 1.21 .78 .97 1.46 1.78 2.74
Edg6
KLA  ATP  ATP+KLA
 NM_010102 endothelial differentiation, G-protein-coupled receptor 6 (Edg6), mRNA [NM_010102] KLA 1.26 1.27 1.19 1.42 1.23 1.23 1.31
ATP 1.02 1.01 1.09 1.44 2.79 1.74 1.30
KLA/ATP 1.35 1.28 1.41 1.28 2.43 2.58 1.26
Edg8
KLA  ATP  ATP+KLA
 NM_053190 endothelial differentiation, sphingolipid G-protein-coupled receptor, 8 (Edg8), mRNA [NM_053190] KLA 1.00 .98 1.01 .98 1.02 .99 1.17
ATP 1.02 1.01 .94 1.02 1.01 1.00 1.02
KLA/ATP 1.03 1.04 .96 .98 1.02 .97 .96
Edn1
KLA  ATP  ATP+KLA
 NM_010104 endothelin 1 (Edn1), mRNA [NM_010104] KLA 73.36 71.33 61.92 68.69 46.94 32.60 13.54
ATP 1.23 1.89 4.18 10.86 17.85 11.03 1.91
KLA/ATP 67.27 76.78 116.70 90.29 76.38 29.71 8.04
Edn2
KLA  ATP  ATP+KLA
 NM_007902 endothelin 2 (Edn2), mRNA [NM_007902] KLA 1.01 .97 1.01 1.04 1.03 1.03 1.09
ATP 1.03 1.06 .97 1.02 .98 .99 1.01
KLA/ATP 1.07 .99 .96 1.03 1.03 1.11 1.03
Edn3
KLA  ATP  ATP+KLA
 NM_007903 endothelin 3 (Edn3), mRNA [NM_007903] KLA .98 1.00 .99 1.00 .99 1.00 1.03
ATP .99 .99 .99 1.03 1.00 1.04 1.01
KLA/ATP 1.02 .97 1.00 1.06 .99 1.04 .99
Ednra
KLA  ATP  ATP+KLA
 AK042211 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630071G03 product:SIMILAR TO ENDOTHELIN RECEPTOR TYPE A, full insert sequence. [AK042211] KLA 1.00 1.03 1.03 .97 .98 .99 .99
ATP .96 .97 1.05 .95 1.05 1.04 1.02
KLA/ATP .99 .98 1.00 1.05 .97 .98 .83
Ednra
KLA  ATP  ATP+KLA
 NM_010332 endothelin receptor type A (Ednra), mRNA [NM_010332] KLA 1.06 .99 1.02 .91 1.05 1.00 .99
ATP 1.01 .98 1.03 .98 .98 1.03 1.06
KLA/ATP 1.01 1.06 1.04 .93 .92 .92 .97
Ednrb
KLA  ATP  ATP+KLA
 NM_007904 endothelin receptor type B (Ednrb), mRNA [NM_007904] KLA 3.53 3.62 3.97 2.91 1.91 1.83 .88
ATP .97 .95 1.05 1.80 4.84 18.19 9.14
KLA/ATP 3.30 3.37 3.89 3.06 2.11 4.82 10.15
F2
KLA  ATP  ATP+KLA
 NM_010168 coagulation factor II (F2), mRNA [NM_010168] KLA .99 .92 .95 1.01 1.01 1.06 .97
ATP 1.03 1.02 1.04 1.07 1.08 .96 .99
KLA/ATP .95 1.04 1.02 1.02 1.04 1.07 .99
F2r
KLA  ATP  ATP+KLA
 NM_010169 coagulation factor II (thrombin) receptor (F2r), mRNA [NM_010169] KLA 3.73 3.81 3.68 3.00 2.75 1.49 1.01
ATP .98 1.02 1.25 1.24 1.31 1.63 1.16
KLA/ATP 3.51 4.05 3.49 3.00 2.48 1.69 1.23
F2rl1
KLA  ATP  ATP+KLA
 NM_007974 coagulation factor II (thrombin) receptor-like 1 (F2rl1), mRNA [NM_007974] KLA 1.03 1.05 1.00 .98 1.01 1.03 1.04
ATP 1.00 .99 1.03 1.09 1.03 1.04 1.09
KLA/ATP 1.07 1.02 .95 1.10 1.02 1.02 1.02
F2rl2
KLA  ATP  ATP+KLA
 NM_010170 coagulation factor II (thrombin) receptor-like 2 (F2rl2), mRNA [NM_010170] KLA 1.04 1.02 .99 1.00 1.07 1.02 .96
ATP .98 1.01 1.00 .92 1.00 .98 .98
KLA/ATP 1.04 1.00 .95 .94 1.04 .99 .94
F2rl3
KLA  ATP  ATP+KLA
 NM_007975 coagulation factor II (thrombin) receptor-like 3 (F2rl3), mRNA [NM_007975] KLA 1.02 .92 1.01 .98 .91 .97 .96
ATP .99 .95 .99 .95 1.00 .98 1.01
KLA/ATP 1.03 .99 1.04 .94 .95 .98 .87
Fpr1
KLA  ATP  ATP+KLA
 NM_013521 formyl peptide receptor 1 (Fpr1), mRNA [NM_013521] KLA 12.54 11.98 13.69 17.91 17.62 21.59 20.02
ATP 1.09 1.02 1.66 1.90 2.46 10.47 6.95
KLA/ATP 10.93 13.61 16.67 13.71 13.37 13.41 21.96
Fpr2
KLA  ATP  ATP+KLA
 NM_008039 formyl peptide receptor 2 (Fpr2), mRNA [NM_008039] KLA 30.10 32.49 33.82 36.00 37.31 42.10 32.37
ATP 1.10 1.05 1.45 1.72 2.69 13.48 7.36
KLA/ATP 27.60 31.79 38.83 33.94 35.28 33.33 38.38
Fshb
KLA  ATP  ATP+KLA
 NM_008045 follicle stimulating hormone beta (Fshb), mRNA [NM_008045] KLA 1.05 1.05 1.01 .98 1.05 1.03 1.07
ATP 1.02 1.01 1.02 .94 1.02 1.02 .96
KLA/ATP 1.10 1.03 .99 1.00 1.07 1.06 .98
Fshr
KLA  ATP  ATP+KLA
 NM_013523 follicle stimulating hormone receptor (Fshr), mRNA [NM_013523] KLA .98 1.03 .89 .95 .99 1.01 .98
ATP 1.01 1.03 1.02 .96 .95 .97 1.04
KLA/ATP .93 .94 1.06 .97 .92 .93 1.03
Gabbr1
KLA  ATP  ATP+KLA
 NM_019439 gamma-aminobutyric acid (GABA-B) receptor, 1 (Gabbr1), mRNA [NM_019439] KLA 1.00 1.03 1.04 1.01 .97 1.01 .99
ATP .98 .96 1.03 1.01 .96 1.03 .99
KLA/ATP .97 1.00 .97 1.02 1.02 .97 1.01
Gabbr2
KLA  ATP  ATP+KLA
 NM_001081141 gamma-aminobutyric acid (GABA) B receptor 2 (Gabbr2), mRNA [NM_001081141] KLA 1.06 .98 .99 1.03 1.09 1.06 1.02
ATP 1.03 1.06 1.05 1.14 1.10 1.00 1.04
KLA/ATP 1.09 1.10 1.12 1.11 1.06 1.04 1.06
Gabra1
KLA  ATP  ATP+KLA
 NM_010250 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 1 (Gabra1), mRNA [NM_010250] KLA 1.01 .99 1.01 1.06 1.00 1.07 1.04
ATP 1.03 1.04 1.07 1.05 1.02 .99 .99
KLA/ATP 1.05 1.02 1.04 1.06 1.05 1.06 1.01
Gabra2
KLA  ATP  ATP+KLA
 AK048165 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130038H23 product:gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 2, full insert sequence [AK048165] KLA .98 1.06 1.03 1.01 1.03 1.03 .98
ATP 1.00 1.00 1.05 1.07 .96 .92 1.04
KLA/ATP 1.02 1.09 .97 1.02 .99 .98 .80
Gabra2
KLA  ATP  ATP+KLA
 NM_008066 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 2 (Gabra2), mRNA [NM_008066] KLA .99 1.01 1.10 1.05 .96 .93 .98
ATP 1.09 .99 .99 .98 .97 .93 .94
KLA/ATP .99 .97 .97 .96 1.02 .97 1.04
Gabra3
KLA  ATP  ATP+KLA
 NM_008067 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 (Gabra3), mRNA [NM_008067] KLA 1.00 1.01 1.03 .99 1.01 1.00 1.01
ATP 1.03 .97 1.03 .98 .98 .97 1.00
KLA/ATP .99 1.08 1.05 .98 1.00 1.03 .96
Gabra4
KLA  ATP  ATP+KLA
 NM_010251 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 (Gabra4), mRNA [NM_010251] KLA .98 1.01 1.02 .99 1.03 .95 1.02
ATP .98 .94 1.03 1.09 1.00 1.06 1.03
KLA/ATP 1.04 1.00 1.02 .97 1.02 1.05 .98
Gabra5
KLA  ATP  ATP+KLA
 NM_176942 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 (Gabra5), mRNA [NM_176942] KLA .97 .92 1.00 .97 1.01 .99 .97
ATP 1.02 .99 1.03 .98 1.00 .98 1.00
KLA/ATP .97 .99 1.01 1.00 .97 .97 .92
Gabra6
KLA  ATP  ATP+KLA
 NM_008068 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 (Gabra6), transcript variant 2, mRNA [NM_008068] KLA 1.05 1.02 .96 1.06 .96 1.02 1.07
ATP 1.01 .96 1.03 1.00 .99 .94 1.07
KLA/ATP .99 .99 1.09 1.01 1.13 .97 1.07
Gabrb1
KLA  ATP  ATP+KLA
 NM_008069 gamma-aminobutyric acid (GABA-A) receptor, subunit beta 1 (Gabrb1), mRNA [NM_008069] KLA .99 .98 .99 1.00 1.02 .99 .95
ATP 1.00 1.04 .98 1.01 1.05 1.02 1.03
KLA/ATP 1.00 .96 1.00 .96 1.05 1.03 1.04
Gabrb2
KLA  ATP  ATP+KLA
 NM_008070 gamma-aminobutyric acid (GABA-A) receptor, subunit beta 2 (Gabrb2), mRNA [NM_008070] KLA 1.04 1.04 1.03 1.04 1.00 .98 1.03
ATP .99 1.01 1.00 1.01 1.03 .99 .93
KLA/ATP 1.05 1.06 1.05 .96 .97 .94 1.00
Gabrb3
KLA  ATP  ATP+KLA
 NM_008071 gamma-aminobutyric acid (GABA-A) receptor, subunit beta 3 (Gabrb3), transcript variant 1, mRNA [NM_008071] KLA .99 .99 .99 1.01 .99 .97 1.00
ATP .98 1.02 1.00 .99 .99 .99 1.00
KLA/ATP 1.00 1.03 1.05 .97 .98 .99 .99
Gabrd
KLA  ATP  ATP+KLA
 NM_008072 gamma-aminobutyric acid (GABA-A) receptor, subunit delta (Gabrd), mRNA [NM_008072] KLA 1.36 1.25 1.30 1.25 1.16 1.42 1.07
ATP .97 .82 .91 .80 .74 1.02 .96
KLA/ATP 1.12 1.10 1.06 .87 .89 1.04 1.12
Gabre
KLA  ATP  ATP+KLA
 NM_017369 gamma-aminobutyric acid (GABA-A) receptor, subunit epsilon (Gabre), mRNA [NM_017369] KLA .97 1.04 .98 1.01 1.03 .99 1.05
ATP .96 1.00 .96 1.04 .98 .99 1.02
KLA/ATP 1.00 1.02 1.01 .97 .93 .93 .89
Gabrg1
KLA  ATP  ATP+KLA
 AK038686 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230055A07 product:gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 1, full insert sequence. [AK038686] KLA .98 1.06 1.09 1.00 1.01 1.05 1.07
ATP .96 .99 1.03 1.03 1.03 1.00 1.08
KLA/ATP 1.04 1.04 .90 1.04 1.04 1.08 1.07
Gabrg1
KLA  ATP  ATP+KLA
 NM_010252 gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 1 (Gabrg1), mRNA [NM_010252] KLA 1.00 1.00 .98 .99 1.01 1.01 1.01
ATP 1.00 .99 1.00 1.03 1.01 1.02 1.01
KLA/ATP .98 .98 1.00 1.00 1.00 1.00 1.02
Gabrg2
KLA  ATP  ATP+KLA
 NM_008073 gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 2 (Gabrg2), transcript variant 1, mRNA [NM_008073] KLA 1.04 1.03 1.03 .97 .99 .98 1.03
ATP .97 1.00 1.05 1.00 1.01 1.01 1.01
KLA/ATP 1.01 .94 1.04 1.06 1.01 .95 1.02
Gabrg3
KLA  ATP  ATP+KLA
 NM_008074 gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 3 (Gabrg3), mRNA [NM_008074] KLA .98 1.03 1.01 1.05 1.01 1.08 1.09
ATP 1.04 1.09 1.02 1.06 1.07 1.05 1.06
KLA/ATP 1.01 1.14 1.07 1.04 1.04 1.15 1.01
Gabrp
KLA  ATP  ATP+KLA
 NM_146017 gamma-aminobutyric acid (GABA-A) receptor, pi (Gabrp), mRNA [NM_146017] KLA 1.03 .97 .99 1.08 .98 1.08 1.00
ATP .95 1.04 1.03 .95 .95 .95 1.05
KLA/ATP .97 .98 .98 .98 .95 .94 .86
Gabrq
KLA  ATP  ATP+KLA
 NM_020488 gamma-aminobutyric acid (GABA-A) receptor, subunit theta (Gabrq), mRNA [NM_020488] KLA 1.00 .97 1.04 1.02 1.02 .88 .96
ATP 1.03 1.03 .99 .94 1.05 .94 .90
KLA/ATP .94 1.00 1.03 .93 .98 1.01 1.01
Gabrr1
KLA  ATP  ATP+KLA
 NM_008075 gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 (Gabrr1), mRNA [NM_008075] KLA 1.37 1.28 1.42 1.45 1.28 1.19 1.01
ATP .99 1.01 1.30 1.10 1.13 1.05 .80
KLA/ATP 1.25 1.36 1.40 1.29 1.16 1.00 .79
Gabrr2
KLA  ATP  ATP+KLA
 NM_008076 gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 (Gabrr2), mRNA [NM_008076] KLA 1.03 1.04 .99 1.02 1.05 .98 1.12
ATP 1.07 .98 1.00 1.08 1.04 .97 1.02
KLA/ATP 1.04 1.00 .94 .99 1.05 1.05 1.05
Gal
KLA  ATP  ATP+KLA
 NM_010253 galanin (Gal), mRNA [NM_010253] KLA .98 1.00 1.09 1.08 1.09 .98 1.09
ATP 1.07 1.06 1.16 1.77 1.93 1.74 1.57
KLA/ATP 1.20 1.08 1.23 1.43 1.54 1.45 1.38
Galr1
KLA  ATP  ATP+KLA
 NM_008082 galanin receptor 1 (Galr1), mRNA [NM_008082] KLA .98 1.01 1.08 1.07 1.02 1.00 .95
ATP 1.02 1.00 .94 .98 .98 1.00 .94
KLA/ATP .95 1.11 .96 1.01 1.00 .95 1.00
Galr2
KLA  ATP  ATP+KLA
 NM_010254 galanin receptor 2 (Galr2), mRNA [NM_010254] KLA 1.00 1.04 1.08 .96 1.02 1.04 1.03
ATP 1.06 1.12 1.10 1.08 1.05 1.03 1.02
KLA/ATP 1.01 1.05 1.06 1.00 .98 1.00 1.02
Galr3
KLA  ATP  ATP+KLA
 NM_015738 galanin receptor 3 (Galr3), mRNA [NM_015738] KLA 1.22 1.17 1.32 1.30 1.34 1.45 1.18
ATP 1.03 1.00 1.28 1.39 1.38 1.36 1.21
KLA/ATP 1.27 1.39 1.61 1.67 1.57 1.57 1.44
Gcg
KLA  ATP  ATP+KLA
 AK050538 adult pancreas islet cells cDNA, RIKEN full-length enriched library, clone:C820012C23 product:unclassifiable, full insert sequence [AK050538] KLA 1.02 1.03 1.02 1.04 1.01 .95 .98
ATP .95 .95 1.02 .98 .93 1.06 1.02
KLA/ATP 1.02 1.02 1.07 1.24 1.07 1.05 1.02
Gcg
KLA  ATP  ATP+KLA
 NM_008100 glucagon (Gcg), mRNA [NM_008100] KLA 1.15 1.16 1.18 1.14 1.12 1.11 1.07
ATP 1.00 1.01 1.05 1.06 1.34 1.43 1.08
KLA/ATP 1.15 1.16 1.27 7.81 6.64 5.01 1.81
Gcgr
KLA  ATP  ATP+KLA
 L38613 glucagon receptor mRNA, complete cds. [L38613] KLA .95 1.03 1.02 1.03 1.01 1.00 1.04
ATP .93 1.02 1.00 .96 1.09 .90 .95
KLA/ATP .98 1.09 1.01 1.01 .99 1.04 .96
Gh
KLA  ATP  ATP+KLA
 NM_008117 growth hormone (Gh), mRNA [NM_008117] KLA 1.02 1.03 1.01 .98 .98 .94 .98
ATP .94 1.02 1.06 1.20 .99 .95 .96
KLA/ATP .97 1.03 1.03 1.09 .96 1.00 1.05
Ghr
KLA  ATP  ATP+KLA
 AK053579 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111P21 product:growth hormone receptor, full insert sequence. [AK053579] KLA 1.10 1.07 1.09 1.01 1.03 .96 1.02
ATP 1.04 1.01 1.06 .96 1.03 .96 1.02
KLA/ATP 1.08 1.15 1.15 1.04 1.02 1.07 1.03
Ghr
KLA  ATP  ATP+KLA
 NM_010284 growth hormone receptor (Ghr), transcript variant 1, mRNA [NM_010284] KLA 1.09 1.10 1.29 1.31 1.23 1.09 .97
ATP 1.00 1.02 1.03 1.02 .93 .96 .97
KLA/ATP 1.17 1.20 1.15 1.15 1.07 .96 .96
Ghrh
KLA  ATP  ATP+KLA
 NM_010285 growth hormone releasing hormone (Ghrh), mRNA [NM_010285] KLA 1.02 1.08 1.04 1.08 1.09 1.03 .96
ATP .98 .97 .98 .97 1.01 1.04 .92
KLA/ATP 1.01 1.07 1.10 .99 1.04 .94 .98
Ghrhr
KLA  ATP  ATP+KLA
 NM_001003685 growth hormone releasing hormone receptor (Ghrhr), mRNA [NM_001003685] KLA 1.05 .98 1.02 .97 1.02 .92 1.01
ATP 1.07 .97 1.05 .98 1.03 .95 1.02
KLA/ATP 1.06 1.10 1.02 1.03 1.02 .99 .91
Ghrl
KLA  ATP  ATP+KLA
 NM_021488 ghrelin (Ghrl), mRNA [NM_021488] KLA 1.07 1.08 1.05 1.08 1.12 1.09 1.01
ATP .97 1.02 1.19 1.22 1.19 1.20 .97
KLA/ATP 1.02 1.01 1.09 1.21 1.21 1.29 1.13
Ghsr
KLA  ATP  ATP+KLA
 NM_177330 growth hormone secretagogue receptor (Ghsr), mRNA [NM_177330] KLA 1.02 .95 1.04 1.05 1.00 1.07 1.03
ATP .99 1.01 1.01 .98 1.08 .99 1.03
KLA/ATP 1.01 1.07 1.03 1.03 1.04 1.03 1.05
Gip
KLA  ATP  ATP+KLA
 NM_008119 gastric inhibitory polypeptide (Gip), mRNA [NM_008119] KLA 1.07 1.03 .94 1.06 1.10 1.03 1.05
ATP 1.05 1.00 .96 1.00 .96 .97 .97
KLA/ATP .92 .95 1.04 1.00 .95 1.03 1.02
Gipr
KLA  ATP  ATP+KLA
 NM_001080815 gastric inhibitory polypeptide receptor (Gipr), mRNA [NM_001080815] KLA 1.09 1.06 1.06 1.04 1.08 1.06 1.10
ATP 1.02 1.03 .96 .96 1.05 1.04 1.16
KLA/ATP 1.04 1.03 1.07 1.00 .97 1.01 1.30
Glp1r
KLA  ATP  ATP+KLA
 NM_021332 glucagon-like peptide 1 receptor (Glp1r), mRNA [NM_021332] KLA .99 .97 .98 .95 1.03 .99 .99
ATP .99 .99 .97 1.01 .97 .99 1.02
KLA/ATP .97 1.03 1.02 1.00 .98 .98 1.01
Glp2r
KLA  ATP  ATP+KLA
 NM_175681 glucagon-like peptide 2 receptor (Glp2r), mRNA [NM_175681] KLA 1.03 1.01 1.04 1.07 1.02 .97 1.02
ATP 1.02 .96 1.04 1.06 1.03 1.02 1.02
KLA/ATP 1.05 1.07 1.11 1.03 1.01 1.05 1.06
Glra1
KLA  ATP  ATP+KLA
 NM_020492 glycine receptor, alpha 1 subunit (Glra1), mRNA [NM_020492] KLA 1.01 1.01 1.01 1.01 1.02 1.05 .97
ATP .99 .97 1.24 1.28 1.04 1.01 1.04
KLA/ATP 1.01 1.06 1.06 1.18 1.07 1.01 1.05
Glra2
KLA  ATP  ATP+KLA
 NM_183427 glycine receptor, alpha 2 subunit (Glra2), mRNA [NM_183427] KLA .98 .97 .99 1.00 1.02 1.05 1.01
ATP .98 .93 1.04 .97 .97 1.07 1.05
KLA/ATP .98 .97 1.06 1.02 .97 .99 1.04
Glra3
KLA  ATP  ATP+KLA
 AK038618 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230050P16 product:glycine receptor, alpha 3 subunit, full insert sequence [AK038618] KLA .94 .95 .96 1.03 1.00 1.03 1.03
ATP 1.06 1.02 1.06 1.06 .98 1.04 1.03
KLA/ATP 1.03 .93 .87 .97 1.08 1.06 1.02
Glra3
KLA  ATP  ATP+KLA
 NM_080438 glycine receptor, alpha 3 subunit (Glra3), mRNA [NM_080438] KLA 1.00 1.02 1.03 .97 .97 1.04 .99
ATP .99 .93 .96 1.06 .96 1.05 1.02
KLA/ATP .99 1.03 .95 .97 1.05 1.07 1.04
Glrb
KLA  ATP  ATP+KLA
 NM_010298 glycine receptor, beta subunit (Glrb), mRNA [NM_010298] KLA 1.05 1.00 1.10 .98 .99 1.03 .94
ATP .93 1.02 1.06 1.02 .96 1.04 1.04
KLA/ATP 1.06 .96 .96 .99 .94 .96 1.02
Gnrh1
KLA  ATP  ATP+KLA
 NM_008145 gonadotropin releasing hormone 1 (Gnrh1), mRNA [NM_008145] KLA .80 .84 .94 .97 .93 1.04 .97
ATP 1.01 1.10 1.21 1.12 3.15 1.61 .95
KLA/ATP .84 .92 1.03 .93 2.48 1.56 1.23
Gnrhr
KLA  ATP  ATP+KLA
 NM_010323 gonadotropin releasing hormone receptor (Gnrhr), mRNA [NM_010323] KLA 1.01 .98 1.04 1.00 1.01 .96 .99
ATP 1.03 1.00 .98 1.06 1.01 1.00 .99
KLA/ATP 1.05 1.04 1.00 .97 1.00 .98 1.08
Gpr156
KLA  ATP  ATP+KLA
 NM_153394 G protein-coupled receptor 156 (Gpr156), mRNA [NM_153394] KLA .99 1.03 .99 .99 1.05 1.03 .99
ATP .99 1.02 1.03 1.00 .96 1.02 1.05
KLA/ATP 1.01 1.00 1.02 1.00 1.00 1.05 .98
Gpr35
KLA  ATP  ATP+KLA
 NM_022320 G protein-coupled receptor 35 (Gpr35), transcript variant 1, mRNA [NM_022320] KLA 1.08 1.10 1.09 1.49 2.77 2.80 1.59
ATP 1.02 1.07 1.15 1.20 1.17 2.25 2.87
KLA/ATP 1.05 1.04 1.16 1.31 1.45 3.76 6.97
Gpr50
KLA  ATP  ATP+KLA
 NM_010340 G-protein-coupled receptor 50 (Gpr50), mRNA [NM_010340] KLA .78 .82 .79 .88 .85 .88 1.02
ATP .98 1.08 .90 .97 .89 .81 .89
KLA/ATP .84 .82 .86 .93 .79 .75 .90
Gpr77
KLA  ATP  ATP+KLA
 NM_176912 G protein-coupled receptor 77 (Gpr77), mRNA [NM_176912] KLA .33 .32 .26 .29 .29 .45 .57
ATP .94 .97 1.22 .92 .37 .35 .76
KLA/ATP .33 .38 .45 .37 .35 .23 .67
Gpr83
KLA  ATP  ATP+KLA
 AK041527 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630019F13 product:PROBABLE G PROTEIN-COUPLED RECEPTOR GPR72 PRECURSOR (GLUCOCORTICOID- INDUCED RECEPTOR), full insert sequence [AK041527] KLA 1.00 1.05 1.02 1.05 1.01 1.01 1.00
ATP 1.02 1.04 .95 1.05 1.00 1.04 1.03
KLA/ATP .97 1.01 1.00 1.02 1.00 1.09 1.01
Gpr83
KLA  ATP  ATP+KLA
 NM_010287 G protein-coupled receptor 83 (Gpr83), mRNA [NM_010287] KLA 1.01 .97 1.02 1.03 1.00 1.05 1.05
ATP .92 1.09 .97 1.03 1.26 1.50 1.10
KLA/ATP 1.01 1.04 1.11 1.05 1.21 1.59 1.12
Gria1
KLA  ATP  ATP+KLA
 NM_008165 glutamate receptor, ionotropic, AMPA1 (alpha 1) (Gria1), transcript variant 2, mRNA [NM_008165] KLA .97 1.02 1.02 1.01 1.03 1.02 1.11
ATP 1.03 .97 1.05 1.03 1.01 1.01 1.01
KLA/ATP 1.02 .99 1.01 1.06 1.15 1.06 1.05
Gria2
KLA  ATP  ATP+KLA
 BC048248 glutamate receptor, ionotropic, AMPA2 (alpha 2), mRNA (cDNA clone MGC:54603 IMAGE:6494013), complete cds. [BC048248] KLA 1.00 1.01 1.05 1.00 1.03 .97 1.06
ATP .98 1.00 1.00 .96 1.03 1.05 1.04
KLA/ATP .98 1.08 .99 1.04 1.06 1.02 1.05
Gria2
KLA  ATP  ATP+KLA
 NM_013540 glutamate receptor, ionotropic, AMPA2 (alpha 2) (Gria2), transcript variant 2, mRNA [NM_013540] KLA 1.02 1.02 .98 1.01 .98 1.02 1.01
ATP .95 1.01 .95 .99 1.09 1.02 1.09
KLA/ATP 1.06 .92 .96 .99 1.00 1.03 1.00
Gria3
KLA  ATP  ATP+KLA
 AK161163 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831401I16 product:glutamate receptor, ionotropic, AMPA3 (alpha 3), full insert sequence. [AK161163] KLA 1.01 .96 .97 .95 .99 .84 .81
ATP 1.05 1.04 1.07 .86 .88 .84 .65
KLA/ATP .94 .95 1.06 .83 .79 .75 .66
Gria3
KLA  ATP  ATP+KLA
 NM_016886 glutamate receptor, ionotropic, AMPA3 (alpha 3) (Gria3), mRNA [NM_016886] KLA 1.04 .95 1.05 .98 .98 .97 .95
ATP 1.00 1.08 1.01 .97 .93 .98 .97
KLA/ATP 1.03 .93 .93 .98 .96 1.03 .89
Gria4
KLA  ATP  ATP+KLA
 NM_019691 glutamate receptor, ionotropic, AMPA4 (alpha 4) (Gria4), transcript variant 1, mRNA [NM_019691] KLA 1.05 1.05 1.00 .97 1.00 1.04 1.01
ATP 1.01 1.03 1.24 .99 .95 .99 1.02
KLA/ATP .99 1.03 1.04 1.00 .98 .97 1.02
Grid1
KLA  ATP  ATP+KLA
 NM_008166 glutamate receptor, ionotropic, delta 1 (Grid1), mRNA [NM_008166] KLA 1.06 .99 1.07 1.00 .97 1.00 1.01
ATP 1.08 1.05 1.05 .97 .95 1.00 1.04
KLA/ATP 1.03 .95 1.13 1.00 1.06 1.00 .97
Grid2
KLA  ATP  ATP+KLA
 AK032669 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:6530411F08 product:glutamate receptor, ionotropic, delta 2, full insert sequence. [AK032669] KLA 1.00 1.02 1.01 1.01 1.01 1.01 1.00
ATP 1.01 1.01 .99 .99 1.01 1.01 1.00
KLA/ATP 1.02 1.01 1.01 1.02 .99 1.01 .99
Grid2
KLA  ATP  ATP+KLA
 AK036230 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630046P05 product:glutamate receptor, ionotropic, delta 2, full insert sequence. [AK036230] KLA 1.01 .97 1.01 .96 .96 .96 1.06
ATP 1.00 1.01 1.01 .97 1.00 .97 1.03
KLA/ATP 1.02 1.06 1.02 .92 .95 .95 .99
Grik1
KLA  ATP  ATP+KLA
 NM_010348 glutamate receptor, ionotropic, kainate 1 (Grik1), transcript variant 2, mRNA [NM_010348] KLA 1.04 1.05 .99 1.03 .99 1.04 .89
ATP .98 1.06 1.02 .94 .94 1.01 1.08
KLA/ATP 1.07 .95 1.00 .97 1.05 .97 1.03
Grik1
KLA  ATP  ATP+KLA
 NM_146072 glutamate receptor, ionotropic, kainate 1 (Grik1), transcript variant 1, mRNA [NM_146072] KLA 1.00 .98 .99 1.04 .98 .96 .94
ATP .97 .96 1.03 1.02 .94 .94 .97
KLA/ATP .93 1.02 1.01 1.02 1.01 .97 1.02
Grik2
KLA  ATP  ATP+KLA
 NM_010349 glutamate receptor, ionotropic, kainate 2 (beta 2) (Grik2), transcript variant 2, mRNA [NM_010349] KLA 1.04 .99 .97 1.02 1.02 .99 .98
ATP 1.02 1.02 .99 .99 1.01 .98 .96
KLA/ATP .98 1.01 1.03 1.00 .96 .98 1.03
Grik3
KLA  ATP  ATP+KLA
 NM_001081097 glutamate receptor, ionotropic, kainate 3 (Grik3), mRNA [NM_001081097] KLA .97 .98 1.00 1.07 1.08 1.05 .98
ATP 1.00 .98 .98 .99 .98 1.03 1.02
KLA/ATP 1.01 .98 1.06 1.07 .97 1.04 1.03
Grik4
KLA  ATP  ATP+KLA
 NM_175481 glutamate receptor, ionotropic, kainate 4 (Grik4), mRNA [NM_175481] KLA 1.00 1.01 1.01 1.11 1.00 .95 1.03
ATP 1.05 1.02 1.00 1.00 1.12 .91 1.06
KLA/ATP .96 1.01 1.04 .99 .98 1.00 1.05
Grik5
KLA  ATP  ATP+KLA
 NM_008168 glutamate receptor, ionotropic, kainate 5 (gamma 2) (Grik5), mRNA [NM_008168] KLA .88 .88 .91 .89 .86 .87 .87
ATP 1.01 1.03 .97 1.06 .83 .73 .83
KLA/ATP .91 .87 .95 .92 .80 .77 .92
Grin1
KLA  ATP  ATP+KLA
 NM_008169 glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1), mRNA [NM_008169] KLA .90 .97 .91 .98 .93 .94 1.01
ATP 1.04 1.04 1.02 1.08 .96 .91 .93
KLA/ATP .90 .99 .95 .95 .94 .88 .89
Grin2a
KLA  ATP  ATP+KLA
 NM_008170 glutamate receptor, ionotropic, NMDA2A (epsilon 1) (Grin2a), mRNA [NM_008170] KLA 1.00 1.08 1.00 1.03 1.09 1.02 1.04
ATP .96 .94 1.00 .98 1.03 .97 1.01
KLA/ATP .95 1.02 1.03 .95 .99 .99 .95
Grin2b
KLA  ATP  ATP+KLA
 NM_008171 glutamate receptor, ionotropic, NMDA2B (epsilon 2) (Grin2b), mRNA [NM_008171] KLA 1.03 1.02 1.10 1.09 1.02 1.03 1.08
ATP 1.15 1.07 1.05 1.07 1.08 1.04 1.02
KLA/ATP 1.10 1.04 1.07 1.13 1.09 1.08 1.06
Grin2c
KLA  ATP  ATP+KLA
 NM_010350 glutamate receptor, ionotropic, NMDA2C (epsilon 3) (Grin2c), mRNA [NM_010350] KLA 1.09 1.13 1.19 1.24 1.14 1.15 1.09
ATP 1.05 .96 .98 .98 .94 1.01 1.10
KLA/ATP 1.08 1.14 1.09 1.05 1.05 .98 1.01
Grin2d
KLA  ATP  ATP+KLA
 NM_008172 glutamate receptor, ionotropic, NMDA2D (epsilon 4) (Grin2d), mRNA [NM_008172] KLA 1.57 1.18 1.35 1.45 1.25 1.49 .91
ATP .92 .99 1.45 1.66 1.54 2.02 1.15
KLA/ATP 1.23 1.38 2.08 2.28 1.92 2.53 1.92
Grin3a
KLA  ATP  ATP+KLA
 AK044171 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830097C19 product:similar to IONOTROPIC GLUTAMATE RECEPTOR NMDA subunit NR3A[Rattus norvegicus], full insert sequence. [AK044171] KLA 1.06 1.00 .93 .95 .97 .97 .99
ATP .96 .97 1.02 .94 1.03 1.02 1.03
KLA/ATP 1.05 .96 1.05 .98 .94 1.02 1.03
Grin3b
KLA  ATP  ATP+KLA
 NM_130455 glutamate receptor, ionotropic, NMDA3B (Grin3b), mRNA [NM_130455] KLA .90 .92 .88 .98 .91 .91 .69
ATP .96 .93 .94 .92 .93 .84 .68
KLA/ATP .92 .88 .88 .95 .96 .88 .68
Grm1
KLA  ATP  ATP+KLA
 NM_016976 glutamate receptor, metabotropic 1 (Grm1), transcript variant 1, mRNA [NM_016976] KLA 1.16 1.07 1.10 1.18 1.08 1.04 1.15
ATP 1.06 1.05 1.02 .99 1.00 1.09 1.02
KLA/ATP 1.04 1.12 1.06 1.11 1.10 1.32 1.35
Grm2
KLA  ATP  ATP+KLA
 AK015353 adult male testis cDNA, RIKEN full-length enriched library, clone:4930441L02 product:unclassifiable, full insert sequence [AK015353] KLA 1.01 1.07 1.07 1.07 .99 .97 .98
ATP 1.03 1.05 .96 1.04 1.02 .90 .94
KLA/ATP 1.05 1.08 1.02 .99 .94 .98 1.01
Grm2
KLA  ATP  ATP+KLA
 XM_001475814 gb|PREDICTED: Mus musculus G protein-coupled receptor, family C, group 1, member B (Grm2), mRNA [XM_001475814] KLA 1.01 1.02 .94 .98 1.01 .99 .99
ATP 1.03 1.01 1.03 1.03 1.05 1.01 1.03
KLA/ATP 1.02 .97 1.05 1.00 .98 1.02 1.08
Grm3
KLA  ATP  ATP+KLA
 NM_181850 glutamate receptor, metabotropic 3 (Grm3), mRNA [NM_181850] KLA .95 1.00 1.00 1.01 .96 .99 .99
ATP .97 1.02 .99 1.08 1.05 1.02 1.04
KLA/ATP 1.00 .98 .99 1.07 1.07 1.03 1.04
Grm4
KLA  ATP  ATP+KLA
 NM_001013385 glutamate receptor, metabotropic 4 (Grm4), mRNA [NM_001013385] KLA .94 .97 .98 1.01 1.01 1.02 1.08
ATP .99 .94 1.03 .98 .95 .98 1.07
KLA/ATP .99 1.02 .93 1.00 1.02 1.03 1.05
Grm5
KLA  ATP  ATP+KLA
 NM_001081414 glutamate receptor, metabotropic 5 (Grm5), mRNA [NM_001081414] KLA 1.04 1.05 1.04 1.04 1.02 1.01 1.05
ATP .99 1.02 1.03 1.01 .99 1.00 1.03
KLA/ATP 1.03 1.02 1.02 1.03 1.01 1.01 1.05
Grm6
KLA  ATP  ATP+KLA
 BC034118 cDNA clone IMAGE:4511841, containing frame-shift errors [BC034118] KLA 1.00 .92 .99 1.02 .95 1.02 1.04
ATP 1.01 1.01 .99 .94 .94 .98 1.06
KLA/ATP .99 .99 1.01 1.02 1.00 .93 .91
Grm7
KLA  ATP  ATP+KLA
 NM_177328 glutamate receptor, metabotropic 7 (Grm7), mRNA [NM_177328] KLA .97 1.05 .96 1.05 1.02 1.01 1.02
ATP 1.02 .99 1.02 .97 1.00 1.04 1.01
KLA/ATP 1.00 1.00 .96 1.03 1.02 1.00 1.02
Grm8
KLA  ATP  ATP+KLA
 NM_008174 glutamate receptor, metabotropic 8 (Grm8), mRNA [NM_008174] KLA .98 .97 1.01 1.06 .99 .95 1.02
ATP 1.09 1.07 1.10 1.05 1.04 1.02 1.07
KLA/ATP 1.03 1.06 1.06 1.05 1.07 1.10 .93
Grp
KLA  ATP  ATP+KLA
 NM_175012 gastrin releasing peptide (Grp), mRNA [NM_175012] KLA .98 1.01 1.04 1.03 1.01 .95 1.03
ATP .98 1.08 1.00 .97 1.09 1.01 .97
KLA/ATP 1.00 .99 1.03 1.01 1.05 .96 1.02
Grpr
KLA  ATP  ATP+KLA
 NM_008177 gastrin releasing peptide receptor (Grpr), mRNA [NM_008177] KLA 1.00 .96 .99 1.03 .99 1.03 1.04
ATP .95 1.00 1.07 1.00 1.01 1.03 1.05
KLA/ATP .96 1.02 1.06 1.04 .93 1.03 .96
Gzma
KLA  ATP  ATP+KLA
 NM_010370 granzyme A (Gzma), mRNA [NM_010370] KLA 1.04 1.03 .95 .94 .99 .96 .99
ATP 1.01 .93 1.05 1.00 1.03 1.05 1.03
KLA/ATP .98 1.00 1.13 .96 1.02 .99 .99
Hcrt
KLA  ATP  ATP+KLA
 NM_010410 hypocretin (Hcrt), mRNA [NM_010410] KLA 1.01 1.05 1.03 1.06 1.08 1.16 1.08
ATP 1.00 .98 1.07 1.02 1.01 1.03 .98
KLA/ATP .91 .98 1.00 1.15 1.11 1.07 .93
Hcrtr1
KLA  ATP  ATP+KLA
 NM_198959 hypocretin (orexin) receptor 1 (Hcrtr1), mRNA [NM_198959] KLA 1.00 1.05 .98 1.09 1.01 1.02 1.14
ATP .98 1.02 1.01 .98 1.06 1.05 .91
KLA/ATP 1.03 1.03 1.04 1.01 1.07 1.04 .98
Hcrtr2
KLA  ATP  ATP+KLA
 AY336084 orexin receptor type-2a mRNA, complete cds. [AY336084] KLA .99 .98 1.03 .97 .94 .96 1.03
ATP 1.07 1.04 .98 1.03 .98 1.03 1.03
KLA/ATP .99 1.04 1.08 .98 1.00 .99 .99
Hcrtr2
KLA  ATP  ATP+KLA
 NM_198962 hypocretin (orexin) receptor 2 (Hcrtr2), mRNA [NM_198962] KLA 1.05 .99 .98 1.04 1.05 1.02 1.06
ATP .99 1.00 1.02 .92 .96 .99 1.02
KLA/ATP .96 1.03 1.02 .94 1.04 .97 1.02
Hrh1
KLA  ATP  ATP+KLA
 NM_008285 histamine receptor H1 (Hrh1), mRNA [NM_008285] KLA .92 .94 .84 .88 1.27 1.69 1.61
ATP 1.05 .97 .92 .83 .85 .97 1.04
KLA/ATP .86 .89 .83 .74 .87 1.20 2.84
Hrh2
KLA  ATP  ATP+KLA
 NM_008286 histamine receptor H2 (Hrh2), transcript variant 2, mRNA [NM_008286] KLA 1.18 1.33 1.70 1.54 1.69 1.61 1.52
ATP .96 1.10 .98 1.08 .99 1.03 1.35
KLA/ATP 1.25 1.19 1.15 1.20 1.09 1.39 1.92
Hrh3
KLA  ATP  ATP+KLA
 NM_133849 histamine receptor H3 (Hrh3), mRNA [NM_133849] KLA 1.06 .82 1.00 1.06 1.02 1.05 1.14
ATP 1.01 .97 1.02 1.11 1.03 1.05 1.06
KLA/ATP 1.04 1.10 1.02 1.12 1.11 .98 1.05
Hrh4
KLA  ATP  ATP+KLA
 NM_153087 histamine receptor H4 (Hrh4), mRNA [NM_153087] KLA .99 1.02 .99 1.04 1.07 .94 .99
ATP 1.03 1.04 1.14 2.23 1.22 1.01 1.05
KLA/ATP .97 1.07 1.08 1.37 1.17 1.05 .98
Htr1a
KLA  ATP  ATP+KLA
 NM_008308 5-hydroxytryptamine (serotonin) receptor 1A (Htr1a), mRNA [NM_008308] KLA .94 .96 1.04 1.00 .92 1.00 1.01
ATP 1.00 .93 1.03 1.03 1.03 .96 .99
KLA/ATP .98 .96 1.09 1.04 .97 1.08 1.03
Htr1b
KLA  ATP  ATP+KLA
 NM_010482 5-hydroxytryptamine (serotonin) receptor 1B (Htr1b), mRNA [NM_010482] KLA 1.12 .98 1.02 1.08 1.05 1.03 .97
ATP 1.01 1.00 .93 1.04 .95 1.27 1.02
KLA/ATP .98 .96 .97 1.04 1.04 1.00 1.10
Htr1d
KLA  ATP  ATP+KLA
 NM_008309 5-hydroxytryptamine (serotonin) receptor 1D (Htr1d), mRNA [NM_008309] KLA .99 1.01 1.00 1.02 1.00 1.00 .95
ATP .95 .93 .99 1.12 1.01 1.02 1.03
KLA/ATP .97 1.00 1.05 .97 .95 .96 .89
Htr1f
KLA  ATP  ATP+KLA
 NM_008310 5-hydroxytryptamine (serotonin) receptor 1F (Htr1f), mRNA [NM_008310] KLA 1.04 1.02 1.02 1.08 .98 1.03 1.05
ATP 1.03 1.08 1.06 .90 1.01 1.04 1.14
KLA/ATP 1.01 1.02 1.13 1.00 1.11 .98 1.03
Htr2a
KLA  ATP  ATP+KLA
 NM_172812 5-hydroxytryptamine (serotonin) receptor 2A (Htr2a), mRNA [NM_172812] KLA 1.00 1.01 1.03 1.00 .97 .96 .99
ATP .97 .97 .95 1.12 1.41 .98 .95
KLA/ATP .92 1.01 1.07 1.08 1.03 .98 1.06
Htr2b
KLA  ATP  ATP+KLA
 NM_008311 5-hydroxytryptamine (serotonin) receptor 2B (Htr2b), mRNA [NM_008311] KLA .47 .44 .41 .46 .73 1.91 1.14
ATP .90 .92 .95 1.02 1.24 1.47 11.87
KLA/ATP .44 .43 .51 .56 1.05 4.41 10.84
Htr2c
KLA  ATP  ATP+KLA
 AK086348 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930023E13 product:5-hydroxytryptamine (serotonin) receptor 2C, full insert sequence. [AK086348] KLA 1.01 1.01 1.00 1.03 1.03 1.04 1.04
ATP 1.01 1.00 1.00 1.04 1.02 1.03 .99
KLA/ATP .99 1.02 .96 1.07 1.03 1.06 1.06
Htr2c
KLA  ATP  ATP+KLA
 NM_008312 5-hydroxytryptamine (serotonin) receptor 2C (Htr2c), mRNA [NM_008312] KLA 1.03 1.08 1.00 1.05 1.02 1.02 .98
ATP .96 1.02 1.01 1.05 .98 .99 1.03
KLA/ATP 1.00 1.00 1.04 .97 .96 .96 .98
Htr4
KLA  ATP  ATP+KLA
 NM_008313 5 hydroxytryptamine (serotonin) receptor 4 (Htr4), mRNA [NM_008313] KLA 1.02 1.05 .99 .99 1.01 .99 1.08
ATP .98 1.04 1.04 1.06 .96 1.02 1.06
KLA/ATP 1.00 .98 .97 1.03 1.02 1.08 1.00
Htr5a
KLA  ATP  ATP+KLA
 NM_008314 5-hydroxytryptamine (serotonin) receptor 5A (Htr5a), mRNA [NM_008314] KLA 1.08 1.01 1.14 1.10 1.13 1.04 1.08
ATP 1.09 .98 .96 .97 1.04 1.00 1.03
KLA/ATP 1.12 1.08 1.12 .99 1.00 1.03 .98
Htr5b
KLA  ATP  ATP+KLA
 NM_010483 5-hydroxytryptamine (serotonin) receptor 5B (Htr5b), mRNA [NM_010483] KLA .99 .98 1.01 .98 .97 .99 .98
ATP .95 1.00 1.01 1.01 1.01 1.06 .94
KLA/ATP .97 1.00 1.05 1.03 1.00 .93 1.06
Htr6
KLA  ATP  ATP+KLA
 NM_021358 5-hydroxytryptamine (serotonin) receptor 6 (Htr6), mRNA [NM_021358] KLA 1.04 1.01 1.01 1.06 1.05 .98 .97
ATP 1.00 1.03 .96 .96 1.02 .96 1.02
KLA/ATP .93 .94 1.03 1.03 .91 1.00 .91
Htr7
KLA  ATP  ATP+KLA
 NM_008315 5-hydroxytryptamine (serotonin) receptor 7 (Htr7), mRNA [NM_008315] KLA 1.07 .91 1.03 1.05 1.02 1.07 .97
ATP .97 1.02 1.00 1.03 1.05 1.05 .99
KLA/ATP 1.03 1.03 1.10 .99 .99 1.09 1.25
Kiss1r
KLA  ATP  ATP+KLA
 NM_053244 KISS1 receptor (Kiss1r), mRNA [NM_053244] KLA .91 .93 .93 .94 .98 1.04 .95
ATP 1.06 .93 .98 .84 .84 .82 1.00
KLA/ATP .91 .96 .97 .93 .85 .98 .98
Lep
KLA  ATP  ATP+KLA
 NM_008493 leptin (Lep), mRNA [NM_008493] KLA .99 1.00 1.00 .99 .99 .99 1.00
ATP 1.01 1.00 .98 1.01 1.01 .99 .98
KLA/ATP 1.01 1.02 1.01 .97 1.00 1.00 .99
Lepr
KLA  ATP  ATP+KLA
 NM_001122899 leptin receptor (Lepr), transcript variant 3, mRNA [NM_001122899] KLA .98 1.05 1.00 1.03 .98 1.01 1.10
ATP 1.07 .99 .98 1.06 1.08 1.02 1.02
KLA/ATP 1.07 1.03 .99 1.11 1.03 1.12 .98
Lepr
KLA  ATP  ATP+KLA
 NM_010704 leptin receptor (Lepr), transcript variant 2, mRNA [NM_010704] KLA 1.01 1.01 1.03 .99 1.01 1.02 .99
ATP .98 1.00 1.02 1.02 1.02 1.02 1.01
KLA/ATP 1.00 1.00 1.02 1.03 1.00 1.01 .98
Lgr4
KLA  ATP  ATP+KLA
 AK052660 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630016D21 product:unclassifiable, full insert sequence. [AK052660] KLA .98 1.00 .94 .97 1.01 1.00 .98
ATP .96 1.00 1.01 .97 .99 1.01 .96
KLA/ATP 1.02 1.03 .99 1.00 1.00 .99 .92
Lgr4
KLA  ATP  ATP+KLA
 NM_172671 leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4), mRNA [NM_172671] KLA 1.09 1.17 1.09 1.03 1.01 .92 .87
ATP 1.03 1.03 .97 1.03 1.02 1.52 .95
KLA/ATP 1.08 1.09 1.06 1.05 1.01 1.16 1.02
Lgr5
KLA  ATP  ATP+KLA
 AK047873 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130018C02 product:G protein-coupled receptor 49, full insert sequence [AK047873] KLA .97 .95 1.03 1.06 .96 1.01 .98
ATP 1.00 1.00 1.06 .90 1.05 .99 .98
KLA/ATP 1.02 .96 .98 .93 .98 .97 1.01
Lgr5
KLA  ATP  ATP+KLA
 NM_010195 leucine rich repeat containing G protein coupled receptor 5 (Lgr5), mRNA [NM_010195] KLA 1.01 1.03 1.02 1.03 .99 1.03 .90
ATP 1.01 1.00 .98 1.05 .93 1.02 .96
KLA/ATP 1.04 1.06 .97 1.04 1.04 1.00 .70
Lhb
KLA  ATP  ATP+KLA
 AK138425 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230101A12 product:luteinizing hormone beta, full insert sequence [AK138425] KLA 1.06 1.01 1.02 .98 1.00 1.07 .91
ATP 1.02 1.04 .91 .96 .90 1.05 .95
KLA/ATP .98 .96 1.01 1.03 1.04 1.00 1.09
Lhb
KLA  ATP  ATP+KLA
 NM_008497 luteinizing hormone beta (Lhb), mRNA [NM_008497] KLA 1.16 1.26 1.24 1.20 1.29 1.29 1.23
ATP 1.01 1.01 1.12 1.19 1.22 1.21 1.23
KLA/ATP 1.12 1.12 1.33 1.53 1.47 1.42 1.44
Lhcgr
KLA  ATP  ATP+KLA
 NM_013582 luteinizing hormone/choriogonadotropin receptor (Lhcgr), mRNA [NM_013582] KLA .98 1.06 .99 .95 1.01 1.00 1.04
ATP 1.01 .95 1.00 1.04 1.00 1.03 1.00
KLA/ATP 1.04 1.02 .97 1.01 1.03 1.04 .98
Lpar2
KLA  ATP  ATP+KLA
 NM_020028 lysophosphatidic acid receptor 2 (Lpar2), mRNA [NM_020028] KLA .80 .84 .81 .80 .72 .71 .78
ATP 1.08 1.02 1.00 1.14 1.02 .82 .75
KLA/ATP .98 .82 .87 .81 1.06 .76 .69
Lpar3
KLA  ATP  ATP+KLA
 NM_022983 lysophosphatidic acid receptor 3 (Lpar3), mRNA [NM_022983] KLA 1.04 1.04 1.09 1.01 .96 .96 .97
ATP .98 .97 .94 1.07 1.06 1.04 .98
KLA/ATP 1.05 1.14 1.02 1.06 1.24 1.06 1.01
Lpar4
KLA  ATP  ATP+KLA
 NM_175271 lysophosphatidic acid receptor 4 (Lpar4), mRNA [NM_175271] KLA 1.15 1.14 1.12 1.07 .98 1.00 1.04
ATP 1.06 1.00 1.07 .98 .94 .99 .94
KLA/ATP 1.15 1.17 1.14 1.13 1.05 1.08 1.01
Ltb4r1
KLA  ATP  ATP+KLA
 NM_008519 leukotriene B4 receptor 1 (Ltb4r1), mRNA [NM_008519] KLA .81 .83 .81 .92 .97 .98 1.21
ATP 1.07 1.10 1.24 1.29 .94 1.24 5.17
KLA/ATP .77 .83 1.06 1.06 .99 1.10 3.24
Ltb4r2
KLA  ATP  ATP+KLA
 NM_020490 leukotriene B4 receptor 2 (Ltb4r2), mRNA [NM_020490] KLA .97 1.01 1.01 .99 1.03 1.04 1.01
ATP 1.02 .91 1.07 1.01 1.08 1.03 1.01
KLA/ATP .95 1.01 1.00 1.03 1.04 1.01 1.03
M31654
KLA  ATP  ATP+KLA
 M31654 gb|Mouse growth hormone-releasing hormone mRNA, complete cds. [M31654] KLA .94 .96 .97 .95 .85 .89 .97
ATP .98 .94 .99 .95 .93 .93 .92
KLA/ATP .97 .96 1.04 .97 .93 .96 .92
Mas1
KLA  ATP  ATP+KLA
 NM_008552 MAS1 oncogene (Mas1), mRNA [NM_008552] KLA 1.01 .96 1.01 1.00 .99 1.05 1.01
ATP 1.00 .97 .99 1.00 .99 .99 1.01
KLA/ATP .98 1.04 1.01 1.03 1.00 .94 .84
Mc1r
KLA  ATP  ATP+KLA
 NM_008559 melanocortin 1 receptor (Mc1r), mRNA [NM_008559] KLA 1.09 .97 1.02 1.04 .96 .99 .97
ATP 1.02 1.04 .96 1.06 .92 .96 1.03
KLA/ATP 1.04 1.09 .92 1.03 1.02 .98 1.01
Mc2r
KLA  ATP  ATP+KLA
 NM_008560 melanocortin 2 receptor (Mc2r), mRNA [NM_008560] KLA 1.08 1.02 1.03 1.05 1.10 1.07 1.05
ATP 1.05 1.03 1.16 .95 .95 1.00 1.01
KLA/ATP .92 1.02 1.14 .97 .97 .96 .98
Mc3r
KLA  ATP  ATP+KLA
 NM_008561 melanocortin 3 receptor (Mc3r), mRNA [NM_008561] KLA 1.75 2.01 2.04 1.64 1.75 1.63 1.62
ATP 1.02 1.14 1.21 1.71 1.38 1.46 1.52
KLA/ATP 1.91 1.99 1.87 3.16 2.13 1.97 2.31
Mc4r
KLA  ATP  ATP+KLA
 NM_016977 melanocortin 4 receptor (Mc4r), mRNA [NM_016977] KLA 1.11 1.08 1.14 1.31 1.10 1.20 1.06
ATP 1.02 .98 1.21 1.07 1.10 1.02 1.05
KLA/ATP 1.11 1.12 1.24 1.17 1.19 1.00 1.02
Mc5r
KLA  ATP  ATP+KLA
 NM_013596 melanocortin 5 receptor (Mc5r), mRNA [NM_013596] KLA 1.01 .94 1.04 1.04 1.08 1.00 .98
ATP 1.03 1.02 1.01 1.00 .96 1.03 1.00
KLA/ATP 1.06 .98 1.03 1.04 1.08 1.01 .97
Mchr1
KLA  ATP  ATP+KLA
 NM_145132 melanin-concentrating hormone receptor 1 (Mchr1), mRNA [NM_145132] KLA 1.19 1.16 1.18 1.27 1.11 1.31 1.19
ATP 1.10 1.04 1.24 1.16 1.27 1.31 1.05
KLA/ATP 1.14 1.20 1.32 1.40 1.43 1.42 1.25
Mm.20122
KLA  ATP  ATP+KLA
 21703877 Unknown KLA .95 .99 1.04 .93 .93 1.03 .94
ATP 1.01 .94 .92 1.10 .99 .96 .85
KLA/ATP .96 .99 .96 1.16 1.05 1.02 .88
Mm.22329
KLA  ATP  ATP+KLA
 160298175 Unknown KLA .41 .41 .33 .42 .40 .53 .84
ATP .91 .94 1.02 .97 .70 .64 .72
KLA/ATP .37 .36 .45 .41 .55 .58 .53
Mm.23519
3
KLA  ATP  ATP+KLA
 34147202 Unknown KLA .46 .45 .56 .99 1.53 1.74 1.00
ATP .96 .93 .82 .69 .46 .51 1.36
KLA/ATP .44 .41 .35 .38 .43 .49 1.13
Mm.23957
0
KLA  ATP  ATP+KLA
 141802432 Unknown KLA .38 .34 .26 .32 .34 .48 .60
ATP .88 .96 1.17 .89 .38 .35 .71
KLA/ATP .36 .39 .44 .38 .35 .26 .66
Mm.24060
7
KLA  ATP  ATP+KLA
 162951825 Unknown KLA .94 .96 .91 1.02 .90 .84 .97
ATP 1.08 1.01 1.08 .95 1.04 .89 .89
KLA/ATP .93 1.01 1.05 .92 .84 .88 .76
Mm.2408
KLA  ATP  ATP+KLA
 147904678 Unknown KLA .92 .85 1.02 1.30 1.31 1.65 1.62
ATP .92 .87 .90 .60 .44 .36 1.61
KLA/ATP .87 .78 .82 .60 .66 .59 1.06
Mm.28757
2
KLA  ATP  ATP+KLA
 163965437 Unknown KLA .78 .80 1.02 1.85 2.49 1.68 2.10
ATP .83 .79 1.13 .86 3.55 6.26 1.82
KLA/ATP .69 .68 .88 1.30 16.81 15.38 3.29
Mm.29111
0
KLA  ATP  ATP+KLA
 94362689 Unknown KLA 1.07 1.02 .99 1.00 1.03 1.01 1.02
ATP .99 .98 1.01 .97 1.08 1.08 1.07
KLA/ATP 1.00 1.06 1.03 1.01 1.08 1.05 .97
Mm.32259
4
KLA  ATP  ATP+KLA
 144922605 Unknown KLA 1.02 1.03 .98 .98 .95 1.00 1.02
ATP 1.01 .98 1.08 1.01 1.04 1.01 .97
KLA/ATP .97 1.08 1.04 1.02 1.00 1.01 1.03
Mm.33407
4
KLA  ATP  ATP+KLA
 124487260 Unknown KLA 1.01 1.02 .98 .98 .92 .98 1.05
ATP .98 .95 .98 1.06 1.06 .94 .98
KLA/ATP 1.03 1.02 1.10 1.07 1.05 1.02 1.00
Mm.35830
9
KLA  ATP  ATP+KLA
 158517802 Unknown KLA .63 .61 .71 .69 .91 1.05 .78
ATP 1.00 .94 1.06 .83 5.04 3.12 .78
KLA/ATP .62 .59 .86 .69 4.90 2.07 1.10
Mm.37724
1
KLA  ATP  ATP+KLA
 42476093 Unknown KLA 1.05 1.03 .99 1.04 1.00 .99 .97
ATP .96 1.09 1.11 1.08 1.07 1.05 .99
KLA/ATP 1.08 1.03 1.08 .96 1.03 1.06 1.01
Mm.37909
5
KLA  ATP  ATP+KLA
 142358944 Unknown KLA 1.03 1.10 1.11 1.07 1.12 1.15 1.09
ATP 1.01 1.03 1.20 1.24 1.34 1.21 1.12
KLA/ATP 1.17 1.13 1.23 1.33 1.40 1.28 1.09
Mm.38317
1
KLA  ATP  ATP+KLA
 9506412 Unknown KLA .98 1.08 .95 .98 1.01 1.09 1.13
ATP 1.04 1.03 1.03 1.02 .95 .93 1.00
KLA/ATP .98 1.06 .98 1.02 .91 .91 1.10
Mm.40085
KLA  ATP  ATP+KLA
 16716382 Unknown KLA 1.01 .96 .97 .94 .99 .95 .97
ATP 1.00 .89 .91 .97 1.05 1.02 .96
KLA/ATP 1.04 .97 1.01 .97 1.03 .98 .95
Mm.40715
2
KLA  ATP  ATP+KLA
 156766087 Unknown KLA .98 1.00 1.03 1.03 .98 1.01 .96
ATP 1.03 1.01 1.00 .97 1.00 1.04 1.06
KLA/ATP .96 .98 1.03 1.02 1.03 1.03 1.02
Mm.42026
KLA  ATP  ATP+KLA
 84781761 Unknown KLA .55 .55 .60 .65 .79 1.01 .87
ATP .97 .99 1.03 .91 .56 .43 .56
KLA/ATP .60 .58 .68 .58 .85 .96 1.13
Mm.44009
5
KLA  ATP  ATP+KLA
 166158133 Unknown KLA .99 1.03 1.07 1.00 1.07 1.07 1.06
ATP .98 1.01 .98 .94 1.06 .96 .95
KLA/ATP 1.04 1.05 1.00 .97 1.06 .99 .95
Mm.4630
KLA  ATP  ATP+KLA
 144227232 Unknown KLA .80 .84 .78 .81 .79 .88 2.00
ATP .95 .87 1.02 .83 1.79 2.79 2.35
KLA/ATP .84 .79 .79 .76 .89 1.40 2.76
Mm.4716
KLA  ATP  ATP+KLA
 162135953 Unknown KLA 1.04 1.03 .98 .99 .98 .99 1.08
ATP 1.01 1.06 1.08 1.07 1.09 1.03 1.05
KLA/ATP .99 .93 1.03 1.14 1.03 1.09 1.00
Mm.47319
5
KLA  ATP  ATP+KLA
 124358929 Unknown KLA 1.13 1.14 1.12 1.11 1.06 1.03 1.01
ATP 1.05 1.01 .94 1.06 1.06 1.04 .98
KLA/ATP 1.15 1.14 1.20 1.15 1.06 .93 1.01
Mm.5243
KLA  ATP  ATP+KLA
 124244063 Unknown KLA 1.06 1.04 1.06 .98 1.03 1.06 1.04
ATP 1.01 .93 1.02 1.08 .97 1.05 1.03
KLA/ATP 1.16 1.05 1.11 1.01 1.04 1.06 1.10
Mm.54161
KLA  ATP  ATP+KLA
 164607143 Unknown KLA .97 .99 1.00 .98 .95 .98 .94
ATP 1.01 .99 1.06 1.07 1.02 .95 .98
KLA/ATP .93 1.04 1.07 .96 .90 .95 .94
Mm.89984
KLA  ATP  ATP+KLA
 6755930 Unknown KLA 1.08 .97 .96 1.02 1.02 1.03 .99
ATP .98 1.00 .89 .95 .98 .97 1.00
KLA/ATP .94 .96 1.04 1.03 1.00 1.00 1.00
Mtnr1a
KLA  ATP  ATP+KLA
 NM_008639 melatonin receptor 1A (Mtnr1a), mRNA [NM_008639] KLA .99 1.04 1.04 1.05 1.02 1.02 1.02
ATP 1.03 1.00 .99 1.01 1.06 .94 1.02
KLA/ATP 1.02 1.00 1.03 1.05 .98 1.07 .98
Mtnr1b
KLA  ATP  ATP+KLA
 NM_145712 melatonin receptor 1B (Mtnr1b), mRNA [NM_145712] KLA 1.01 .94 .98 1.02 1.03 .95 1.09
ATP .96 1.02 1.03 1.01 1.02 .97 .95
KLA/ATP .96 1.01 .98 .94 .96 .93 1.00
Nmb
KLA  ATP  ATP+KLA
 NM_026523 neuromedin B (Nmb), mRNA [NM_026523] KLA 1.19 1.07 1.12 1.19 1.26 1.15 .73
ATP .99 .82 1.27 1.20 2.74 1.89 1.25
KLA/ATP 1.09 1.05 1.40 1.27 3.04 1.98 1.39
Nmbr
KLA  ATP  ATP+KLA
 NM_008703 neuromedin B receptor (Nmbr), mRNA [NM_008703] KLA .98 .98 1.04 1.03 .96 1.05 .96
ATP 1.00 1.00 1.00 .98 1.05 1.01 .97
KLA/ATP 1.04 .99 1.02 1.02 1.01 1.06 .96
Nmu
KLA  ATP  ATP+KLA
 NM_019515 neuromedin U (Nmu), mRNA [NM_019515] KLA .99 1.04 .94 1.05 .99 1.08 .98
ATP 1.02 .99 1.03 1.11 1.20 1.23 1.38
KLA/ATP 1.02 1.01 .98 1.05 1.29 1.18 1.22
Nmur1
KLA  ATP  ATP+KLA
 NM_010341 neuromedin U receptor 1 (Nmur1), mRNA [NM_010341] KLA 1.10 .97 1.08 1.13 1.18 1.12 1.17
ATP .98 .97 .99 1.06 .96 1.08 1.48
KLA/ATP 1.13 1.12 1.02 1.01 1.01 1.09 1.40
Nmur2
KLA  ATP  ATP+KLA
 NM_153079 neuromedin U receptor 2 (Nmur2), mRNA [NM_153079] KLA 1.00 1.01 1.07 1.00 1.06 1.03 .95
ATP 1.04 .97 .99 .95 .99 1.04 1.07
KLA/ATP 1.00 .97 1.05 .97 .83 1.01 1.08
Npb
KLA  ATP  ATP+KLA
 NM_153288 neuropeptide B (Npb), mRNA [NM_153288] KLA .91 .82 .81 .79 .81 .79 .85
ATP 1.07 1.10 .77 .78 .92 .75 .64
KLA/ATP .89 .85 .73 .78 .89 .82 .73
Npbwr1
KLA  ATP  ATP+KLA
 AK138357 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230077K02 product:similar to Neuropeptides B [AK138357] KLA .97 .98 .98 1.02 1.07 1.06 1.04
ATP 1.04 1.01 1.01 .94 .98 .98 1.04
KLA/ATP 1.01 1.03 1.14 1.02 .99 1.05 1.00
Npff
KLA  ATP  ATP+KLA
 NM_018787 neuropeptide FF-amide peptide precursor (Npff), mRNA [NM_018787] KLA 1.54 1.49 1.50 1.47 1.56 1.38 1.38
ATP 1.21 1.15 1.41 1.70 2.44 1.70 1.05
KLA/ATP 1.75 1.67 1.95 1.77 2.85 2.08 1.69
Npffr1
KLA  ATP  ATP+KLA
 XM_137119 gb|PREDICTED: Mus musculus neuropeptide FF receptor 1 (Npffr1), mRNA [XM_137119] KLA 1.02 1.03 1.01 1.06 1.02 .98 1.04
ATP 1.04 .99 .87 1.00 1.01 1.08 1.05
KLA/ATP .96 1.04 .98 1.01 1.04 .90 .99
Npffr2
KLA  ATP  ATP+KLA
 NM_133192 neuropeptide FF receptor 2 (Npffr2), mRNA [NM_133192] KLA .96 1.00 1.01 .97 1.02 .95 1.01
ATP 1.04 .98 .97 1.01 .99 1.04 .96
KLA/ATP .99 .96 .99 .95 .96 1.01 .96
Npy
KLA  ATP  ATP+KLA
 NM_023456 neuropeptide Y (Npy), mRNA [NM_023456] KLA 1.20 1.09 1.29 1.31 1.37 1.42 1.83
ATP 1.18 1.35 1.22 2.59 2.67 2.65 6.39
KLA/ATP 1.37 1.50 1.23 2.29 2.12 2.71 6.93
Npy1r
KLA  ATP  ATP+KLA
 NM_010934 neuropeptide Y receptor Y1 (Npy1r), mRNA [NM_010934] KLA .95 .92 1.04 .98 .98 .91 .98
ATP 1.00 1.01 .85 .96 .98 .90 .99
KLA/ATP .96 1.05 1.06 .87 1.06 .97 .93
Npy2r
KLA  ATP  ATP+KLA
 NM_008731 neuropeptide Y receptor Y2 (Npy2r), mRNA [NM_008731] KLA 1.07 1.09 .99 1.04 .97 .91 1.00
ATP 1.04 1.04 1.01 1.04 .99 .98 .98
KLA/ATP .98 1.05 .95 1.01 .92 .97 .97
Npy5r
KLA  ATP  ATP+KLA
 NM_016708 neuropeptide Y receptor Y5 (Npy5r), mRNA [NM_016708] KLA .99 .99 1.00 1.02 1.11 .97 1.02
ATP 1.02 1.03 .99 1.01 1.02 1.04 .99
KLA/ATP 1.00 .96 .96 .98 1.05 1.08 1.02
Npy6r
KLA  ATP  ATP+KLA
 NM_010935 neuropeptide Y receptor Y6 (Npy6r), mRNA [NM_010935] KLA 1.00 1.02 1.00 1.00 1.07 1.07 1.04
ATP 1.00 1.02 1.01 1.07 1.01 .97 1.04
KLA/ATP 1.02 .98 .96 1.12 1.06 1.16 .98
Nr3c1
KLA  ATP  ATP+KLA
 NM_008173 nuclear receptor subfamily 3, group C, member 1 (Nr3c1), mRNA [NM_008173] KLA 2.76 2.90 3.44 2.94 2.90 2.08 1.49
ATP 1.10 1.26 1.11 1.22 1.69 2.11 1.22
KLA/ATP 3.00 3.06 2.48 4.07 2.27 2.58 2.95
Nts
KLA  ATP  ATP+KLA
 NM_024435 neurotensin (Nts), mRNA [NM_024435] KLA 1.26 1.30 1.27 1.32 1.20 1.34 1.26
ATP 1.07 1.05 1.11 1.10 1.19 1.13 1.47
KLA/ATP 1.28 1.26 1.36 1.40 1.45 1.88 1.91
Ntsr1
KLA  ATP  ATP+KLA
 NM_018766 neurotensin receptor 1 (Ntsr1), mRNA [NM_018766] KLA 1.04 .98 .97 1.04 1.01 .98 .99
ATP .96 .99 .98 1.00 .94 .99 1.04
KLA/ATP .95 .95 1.06 .99 1.00 .93 .95
Ntsr2
KLA  ATP  ATP+KLA
 NM_008747 neurotensin receptor 2 (Ntsr2), mRNA [NM_008747] KLA .97 1.03 1.01 1.03 1.04 1.02 1.07
ATP 1.00 1.07 1.00 1.05 1.01 1.01 1.04
KLA/ATP 1.01 .94 1.00 1.07 1.03 1.03 1.02
Oprd1
KLA  ATP  ATP+KLA
 NM_013622 opioid receptor, delta 1 (Oprd1), mRNA [NM_013622] KLA .97 .98 1.10 1.01 .98 1.11 1.07
ATP 1.05 .99 1.05 1.04 1.06 1.00 .95
KLA/ATP 1.05 1.03 .89 1.13 1.11 1.18 .97
Oprk1
KLA  ATP  ATP+KLA
 NM_011011 opioid receptor, kappa 1 (Oprk1), mRNA [NM_011011] KLA .96 1.02 1.00 .99 1.00 1.04 1.01
ATP 1.01 .99 .98 1.05 1.02 1.00 1.04
KLA/ATP .98 .94 .97 1.05 1.02 .99 1.03
Oprl1
KLA  ATP  ATP+KLA
 NM_011012 opioid receptor-like 1 (Oprl1), mRNA [NM_011012] KLA 1.49 1.33 1.24 1.25 1.18 1.19 1.11
ATP 1.04 1.12 1.12 1.10 1.05 1.09 1.04
KLA/ATP 1.34 1.36 1.69 1.62 1.17 1.08 1.04
Oprm1
KLA  ATP  ATP+KLA
 NM_001039652 opioid receptor, mu 1 (Oprm1), mRNA [NM_001039652] KLA .98 1.04 .94 .96 .93 .94 1.03
ATP .89 .92 1.06 .98 1.00 1.04 1.01
KLA/ATP .94 .97 1.05 1.00 1.02 1.01 1.00
Oxt
KLA  ATP  ATP+KLA
 NM_011025 oxytocin (Oxt), mRNA [NM_011025] KLA 1.07 1.11 1.14 1.22 1.15 1.13 1.10
ATP .95 .97 1.35 1.69 1.46 1.24 1.08
KLA/ATP 1.04 1.09 1.29 1.28 1.46 1.54 1.29
Oxtr
KLA  ATP  ATP+KLA
 D86599 gb|Mus sp. mRNA for oxytocin receptor, complete cds. [D86599] KLA 1.06 .99 1.04 1.10 1.01 .98 1.02
ATP 1.07 1.04 1.06 .96 1.02 1.01 1.00
KLA/ATP 1.01 1.00 .79 1.04 1.02 .99 1.01
Oxtr
KLA  ATP  ATP+KLA
 NM_001081147 oxytocin receptor (Oxtr), mRNA [NM_001081147] KLA 1.00 1.00 .99 .95 .99 1.00 .99
ATP 1.06 .99 1.00 1.01 .96 .97 1.03
KLA/ATP .94 1.08 1.00 1.00 .94 .94 .98
P2rx1
KLA  ATP  ATP+KLA
 NM_008771 purinergic receptor P2X, ligand-gated ion channel, 1 (P2rx1), mRNA [NM_008771] KLA .98 1.02 1.06 1.04 1.03 .94 .97
ATP 1.00 .97 1.01 .95 .99 1.05 1.03
KLA/ATP 1.08 1.00 1.03 .98 .92 1.01 1.09
P2rx2
KLA  ATP  ATP+KLA
 NM_153400 purinergic receptor P2X, ligand-gated ion channel, 2 (P2rx2), mRNA [NM_153400] KLA 1.15 1.07 1.12 1.19 1.18 1.20 .99
ATP .97 1.09 1.30 1.43 1.29 1.17 1.07
KLA/ATP 1.15 1.13 1.45 1.53 1.38 1.31 1.22
P2rx3
KLA  ATP  ATP+KLA
 AK053021 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930017N16 product:hypothetical protein, full insert sequence. [AK053021] KLA .97 .96 1.03 1.04 1.02 1.00 1.05
ATP 1.00 1.02 1.00 1.03 1.01 .96 1.02
KLA/ATP .96 1.04 .96 .91 .98 1.04 1.02
P2rx3
KLA  ATP  ATP+KLA
 NM_145526 purinergic receptor P2X, ligand-gated ion channel, 3 (P2rx3), mRNA [NM_145526] KLA .86 1.01 1.09 1.01 .99 1.10 1.14
ATP 1.03 .96 1.12 1.14 .96 1.03 .99
KLA/ATP .98 .99 1.09 1.10 1.04 1.06 1.00
P2rx4
KLA  ATP  ATP+KLA
 NM_011026 purinergic receptor P2X, ligand-gated ion channel 4 (P2rx4), mRNA [NM_011026] KLA 1.43 1.51 1.72 1.88 2.11 2.56 3.11
ATP 1.00 .99 .85 .91 .93 1.13 1.98
KLA/ATP 1.50 1.53 1.43 1.30 1.22 1.81 3.72
P2rx5
KLA  ATP  ATP+KLA
 NM_033321 purinergic receptor P2X, ligand-gated ion channel, 5 (P2rx5), mRNA [NM_033321] KLA 1.05 1.08 1.06 1.03 .99 .97 .99
ATP .92 .96 .94 .97 1.02 1.72 3.00
KLA/ATP 1.11 1.04 .98 .96 .98 1.39 2.14
P2rx6
KLA  ATP  ATP+KLA
 AK054195 2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230027A21 product:purinergic receptor P2X-like 1, orphan receptor, full insert sequence. [AK054195] KLA .98 .97 1.02 1.01 1.03 1.01 .98
ATP 1.02 1.06 1.03 .95 1.05 .99 1.01
KLA/ATP .98 1.03 1.03 1.05 1.01 1.06 1.06
P2rx6
KLA  ATP  ATP+KLA
 NM_011028 purinergic receptor P2X, ligand-gated ion channel, 6 (P2rx6), mRNA [NM_011028] KLA .91 .93 .99 1.00 .94 .87 .93
ATP .98 .97 1.05 .95 .96 .91 .93
KLA/ATP 1.03 .92 .99 .88 .89 .90 .88
P2rx7
KLA  ATP  ATP+KLA
 NM_011027 purinergic receptor P2X, ligand-gated ion channel, 7 (P2rx7), transcript variant 1, mRNA [NM_011027] KLA .52 .52 .50 .59 .67 .98 .80
ATP .93 .87 1.11 .79 .57 .48 .52
KLA/ATP .50 .50 .63 .48 .87 .97 1.03
P2ry1
KLA  ATP  ATP+KLA
 NM_008772 purinergic receptor P2Y, G-protein coupled 1 (P2ry1), mRNA [NM_008772] KLA .54 .54 .57 .48 .39 .36 .34
ATP 1.11 1.25 1.33 1.06 .83 .47 .41
KLA/ATP .57 .57 .70 .59 .54 .39 .36
P2ry10
KLA  ATP  ATP+KLA
 NM_172435 purinergic receptor P2Y, G-protein coupled 10 (P2ry10), mRNA [NM_172435] KLA 1.24 1.28 1.23 1.17 1.16 1.08 1.04
ATP 1.02 1.16 1.29 1.47 1.29 1.27 1.07
KLA/ATP 1.29 1.40 1.57 1.68 1.28 1.24 1.27
P2ry13
KLA  ATP  ATP+KLA
 NM_028808 purinergic receptor P2Y, G-protein coupled 13 (P2ry13), mRNA [NM_028808] KLA 2.34 2.64 4.05 3.58 3.00 1.98 .62
ATP 1.05 1.03 1.05 1.11 .86 .92 1.33
KLA/ATP 2.62 2.85 2.91 3.22 1.99 1.61 1.08
P2ry14
KLA  ATP  ATP+KLA
 NM_133200 purinergic receptor P2Y, G-protein coupled, 14 (P2ry14), transcript variant 1, mRNA [NM_133200] KLA 4.59 4.87 6.13 6.05 5.35 4.97 2.90
ATP 1.06 1.01 1.24 1.40 1.09 1.74 2.28
KLA/ATP 4.62 5.16 5.79 7.03 5.62 4.44 4.76
P2ry2
KLA  ATP  ATP+KLA
 NM_008773 purinergic receptor P2Y, G-protein coupled 2 (P2ry2), mRNA [NM_008773] KLA 1.57 1.53 1.38 1.67 2.02 1.28 2.44
ATP 1.00 1.01 1.04 1.96 4.55 3.46 2.23
KLA/ATP 1.63 1.52 1.43 2.61 4.20 2.42 2.17
P2ry4
KLA  ATP  ATP+KLA
 NM_020621 pyrimidinergic receptor P2Y, G-protein coupled, 4 (P2ry4), mRNA [NM_020621] KLA 1.05 .98 1.01 .99 1.08 1.00 1.00
ATP .94 .98 .98 1.00 1.01 .95 1.06
KLA/ATP 1.02 .95 .90 1.01 .99 .99 1.00
P2ry5
KLA  ATP  ATP+KLA
 NM_175116 purinergic receptor P2Y, G-protein coupled, 5 (P2ry5), mRNA [NM_175116] KLA .16 .17 .21 .19 .20 .33 .28
ATP 1.25 1.44 1.75 1.01 .54 1.08 .90
KLA/ATP .17 .17 .26 .27 .35 .49 .57
P2ry6
KLA  ATP  ATP+KLA
 NM_183168 pyrimidinergic receptor P2Y, G-protein coupled, 6 (P2ry6), mRNA [NM_183168] KLA .50 .53 .58 .99 1.48 1.73 1.07
ATP .98 .99 .82 .69 .48 .54 1.39
KLA/ATP .48 .43 .35 .39 .46 .53 1.14
Pard3
KLA  ATP  ATP+KLA
 AK076429 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832405A21 product:par-3 (partitioning defective 3) homolog (C. elegans), full insert sequence. [AK076429] KLA .96 .96 1.03 .96 1.03 .99 1.19
ATP .97 .92 1.09 .99 1.00 1.03 .94
KLA/ATP .97 1.01 .97 1.05 .98 .92 1.04
Pard3
KLA  ATP  ATP+KLA
 NM_001013580 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 2, mRNA [NM_001013580] KLA 1.02 .99 1.03 .97 1.00 .97 1.04
ATP .93 1.02 .98 .95 1.02 1.02 .98
KLA/ATP 1.04 .98 1.01 .99 .96 .91 .95
Pard3
KLA  ATP  ATP+KLA
 NM_001013581 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 1, mRNA [NM_001013581] KLA .99 1.06 1.02 1.02 1.00 .98 .95
ATP .91 1.05 1.06 .99 1.04 .89 .99
KLA/ATP .98 .97 1.09 .97 1.01 .98 1.00
Pard3
KLA  ATP  ATP+KLA
 NM_001122850 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 4, mRNA [NM_001122850] KLA 1.01 .95 1.00 1.01 1.07 .91 .99
ATP 1.00 1.01 .98 .94 1.04 .98 1.00
KLA/ATP .99 .99 1.04 1.04 1.04 1.01 1.03
Pard3
KLA  ATP  ATP+KLA
 NM_033620 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 3, mRNA [NM_033620] KLA .92 .93 .97 .96 1.00 .99 1.02
ATP 1.08 1.03 .93 .92 .99 .97 1.00
KLA/ATP .99 1.03 1.02 1.05 .96 1.06 1.03
Plg
KLA  ATP  ATP+KLA
 NM_008877 plasminogen (Plg), mRNA [NM_008877] KLA 1.02 1.05 1.06 1.02 1.01 1.09 1.07
ATP .99 .96 1.07 1.08 1.02 .95 1.09
KLA/ATP 1.09 .98 .98 1.09 1.21 1.08 1.04
Pomc
KLA  ATP  ATP+KLA
 NM_008895 pro-opiomelanocortin-alpha (Pomc), mRNA [NM_008895] KLA .94 .98 .99 1.06 1.09 1.45 1.61
ATP 1.11 1.02 1.19 1.14 .90 1.39 2.00
KLA/ATP 1.02 1.05 .94 1.20 1.14 1.53 2.62
Ppy
KLA  ATP  ATP+KLA
 NM_008918 pancreatic polypeptide (Ppy), mRNA [NM_008918] KLA .99 1.00 .94 1.04 .96 .95 .98
ATP .97 1.00 .99 .93 .97 1.00 .92
KLA/ATP .99 1.08 1.07 1.01 .97 1.00 1.07
Ppyr1
KLA  ATP  ATP+KLA
 AK035505 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530057L11 product:NEUROPEPTIDE Y RECEPTOR TYPE 4, full insert sequence [AK035505] KLA .92 1.01 1.05 .97 1.03 1.03 1.03
ATP 1.06 1.00 1.01 1.06 .97 .81 .98
KLA/ATP 1.02 .95 1.05 1.12 1.16 1.14 .97
Prl
KLA  ATP  ATP+KLA
 NM_011164 prolactin (Prl), mRNA [NM_011164] KLA 1.01 1.00 1.06 1.02 1.05 .96 .97
ATP .99 1.02 .97 .98 .97 .95 1.00
KLA/ATP 1.00 1.01 1.00 .97 .96 .87 .95
Prlhr
KLA  ATP  ATP+KLA
 NM_201615 prolactin releasing hormone receptor (Prlhr), mRNA [NM_201615] KLA 1.04 1.01 1.03 1.06 1.05 1.14 1.13
ATP 1.03 .97 1.07 1.07 1.10 1.03 .98
KLA/ATP 1.05 1.04 1.05 1.03 .93 1.06 1.11
Prlr
KLA  ATP  ATP+KLA
 AK083198 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630026G18 product:unclassifiable, full insert sequence [AK083198] KLA .99 1.07 1.00 .95 1.01 .90 1.01
ATP 1.02 .94 .97 1.00 .97 .94 .96
KLA/ATP .98 .94 .96 .96 .99 1.07 1.02
Prlr
KLA  ATP  ATP+KLA
 AK087727 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330012C04 product:hypothetical protein, full insert sequence [AK087727] KLA 1.03 1.00 .99 1.01 1.02 1.04 .99
ATP 1.00 .95 1.13 1.06 .97 .98 1.04
KLA/ATP .97 1.01 .88 1.02 1.01 1.03 1.05
Prlr
KLA  ATP  ATP+KLA
 NM_011169 prolactin receptor (Prlr), mRNA [NM_011169] KLA .93 1.03 1.12 1.06 1.05 1.14 1.15
ATP .95 .99 1.11 1.13 1.06 1.19 1.18
KLA/ATP 1.02 1.01 1.05 1.10 1.10 1.21 1.07
Prss2
KLA  ATP  ATP+KLA
 NM_009430 protease, serine, 2 (Prss2), mRNA [NM_009430] KLA .94 .99 .95 1.03 .89 1.08 1.06
ATP 1.04 .95 1.00 1.03 .96 .97 1.00
KLA/ATP 1.05 .96 1.01 1.05 1.00 1.11 1.11
Ptafr
KLA  ATP  ATP+KLA
 AF004858 platelet activating factor receptor mRNA, partial cds. [AF004858] KLA 1.20 1.24 1.22 1.15 1.15 1.23 1.40
ATP 1.03 1.05 1.04 1.19 1.37 1.33 1.63
KLA/ATP 1.28 1.33 1.17 1.25 1.29 1.50 1.90
Ptafr
KLA  ATP  ATP+KLA
 NM_001081211 platelet-activating factor receptor (Ptafr), mRNA [NM_001081211] KLA 1.73 1.73 1.60 1.31 1.61 1.84 2.08
ATP 1.06 1.10 .98 1.24 2.12 2.22 3.21
KLA/ATP 1.93 1.99 1.47 1.65 1.83 2.58 5.06
Ptgdr
KLA  ATP  ATP+KLA
 NM_008962 prostaglandin D receptor (Ptgdr), mRNA [NM_008962] KLA 1.04 1.01 1.01 1.01 1.01 1.02 .97
ATP 1.00 1.02 1.00 .99 .97 1.02 1.05
KLA/ATP .98 1.01 1.01 1.03 .99 1.01 .98
Ptger2
KLA  ATP  ATP+KLA
 NM_008964 prostaglandin E receptor 2 (subtype EP2) (Ptger2), mRNA [NM_008964] KLA .84 .82 .77 .71 .68 .94 3.24
ATP 1.13 1.03 1.05 .80 3.49 4.06 3.47
KLA/ATP .90 .83 .76 .67 .86 2.21 4.62
Ptger3
KLA  ATP  ATP+KLA
 D17406 mRNA for prostaglandin E receptor EP3 subtype, complete cds [D17406] KLA 1.04 .92 1.04 1.06 .98 .97 1.07
ATP .97 .96 1.06 .97 .99 .98 1.07
KLA/ATP 1.00 1.02 .98 1.00 1.01 1.05 .95
Ptger3
KLA  ATP  ATP+KLA
 NM_011196 prostaglandin E receptor 3 (subtype EP3) (Ptger3), mRNA [NM_011196] KLA 1.06 1.00 1.01 .99 .97 .98 .93
ATP 1.00 .98 .94 .99 1.09 1.10 .97
KLA/ATP 1.01 1.02 .92 .96 1.07 1.30 1.08
Ptger4
KLA  ATP  ATP+KLA
 AK051137 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130004L12 product:prostaglandin E receptor 4 (subtype EP4), full insert sequence. [AK051137] KLA 1.01 1.08 .97 1.02 .99 .96 1.04
ATP .99 .99 .96 .98 .98 .94 .93
KLA/ATP 1.02 1.10 .97 1.04 1.03 .98 .93
Ptger4
KLA  ATP  ATP+KLA
 NM_008965 prostaglandin E receptor 4 (subtype EP4) (Ptger4), mRNA [NM_008965] KLA 3.76 3.30 4.81 2.35 2.57 2.66 3.53
ATP 1.24 1.77 2.25 2.62 1.70 .84 .86
KLA/ATP 4.53 4.71 6.35 6.75 2.33 1.13 1.08
Ptgfr
KLA  ATP  ATP+KLA
 AK086563 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930037F10 product:unclassifiable, full insert sequence [AK086563] KLA 1.02 .98 1.02 .98 .99 .95 1.01
ATP .94 1.02 1.02 .96 1.04 1.00 .90
KLA/ATP 1.02 1.07 .99 .87 1.00 1.02 .96
Ptgfr
KLA  ATP  ATP+KLA
 NM_008966 prostaglandin F receptor (Ptgfr), mRNA [NM_008966] KLA 1.07 .96 .99 .99 .97 .97 .98
ATP .94 1.03 .98 1.00 1.03 1.05 1.10
KLA/ATP .95 .97 1.03 1.02 1.02 1.00 .99
Ptgir
KLA  ATP  ATP+KLA
 NM_008967 prostaglandin I receptor (IP) (Ptgir), mRNA [NM_008967] KLA .89 .94 1.08 1.86 2.47 1.66 2.03
ATP .98 .92 1.09 .96 3.20 5.46 1.68
KLA/ATP .83 .83 1.03 1.43 12.77 10.57 2.80
Pth
KLA  ATP  ATP+KLA
 NM_020623 parathyroid hormone (Pth), mRNA [NM_020623] KLA 1.03 1.04 .98 .99 1.01 1.06 1.00
ATP 1.04 1.00 .91 .97 1.00 1.07 1.07
KLA/ATP 1.02 .99 1.01 1.00 .99 1.02 1.05
Pth2r
KLA  ATP  ATP+KLA
 NM_139270 parathyroid hormone 2 receptor (Pth2r), mRNA [NM_139270] KLA .99 1.01 1.05 .98 .96 1.00 .99
ATP 1.00 .97 .97 1.01 .99 .98 .90
KLA/ATP 1.02 1.04 1.04 1.06 1.04 1.04 1.06
Pthr1
KLA  ATP  ATP+KLA
 NM_011199 parathyroid hormone receptor 1 (Pthr1), transcript variant 1, mRNA [NM_011199] KLA .82 .90 .89 .94 .88 .86 .93
ATP 1.08 .95 .93 .89 .83 .86 .85
KLA/ATP .95 .87 .81 .86 .91 .93 .87
Pyy
KLA  ATP  ATP+KLA
 NM_145435 peptide YY (Pyy), mRNA [NM_145435] KLA 1.06 1.04 1.00 1.05 1.08 1.10 1.12
ATP 1.05 1.05 1.19 1.16 1.22 1.08 1.07
KLA/ATP 1.04 1.05 1.04 1.21 1.16 1.06 1.16
Rxfp1
KLA  ATP  ATP+KLA
 AK054129 2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230022G02 product:LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 7 homolog [Homo sapiens], full insert sequence. [AK054129] KLA .99 1.03 .99 1.05 .99 1.03 1.01
ATP 1.01 1.01 .94 .95 .96 .95 1.06
KLA/ATP .98 1.01 1.05 .98 .92 .98 .99
Rxfp1
KLA  ATP  ATP+KLA
 NM_212452 relaxin/insulin-like family peptide receptor 1 (Rxfp1), mRNA [NM_212452] KLA .83 .88 .88 .93 .98 .95 .98
ATP .96 .92 .95 .95 1.00 .96 .92
KLA/ATP .96 .90 .94 .92 .92 .96 .89
Rxfp2
KLA  ATP  ATP+KLA
 AK039086 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230094D06 product:G protein-coupled receptor 106, full insert sequence. [AK039086] KLA 1.05 1.06 1.00 1.01 .98 1.05 1.14
ATP 1.02 1.02 1.01 1.03 .96 1.08 1.03
KLA/ATP 1.01 .99 .96 1.00 .96 1.05 1.02
Rxfp2
KLA  ATP  ATP+KLA
 NM_080468 relaxin/insulin-like family peptide receptor 2 (Rxfp2), mRNA [NM_080468] KLA 1.05 .97 1.03 1.08 1.06 1.03 .99
ATP .96 .95 .91 .96 .97 .94 .99
KLA/ATP 1.06 1.07 1.00 .95 .98 .97 .69
Sct
KLA  ATP  ATP+KLA
 NM_011328 secretin (Sct), mRNA [NM_011328] KLA 1.26 1.40 1.46 1.57 1.67 1.67 1.39
ATP .94 .96 1.00 1.03 1.03 1.00 1.11
KLA/ATP 1.31 1.41 1.24 1.22 1.18 1.20 1.23
Sctr
KLA  ATP  ATP+KLA
 NM_001012322 secretin receptor (Sctr), mRNA [NM_001012322] KLA .96 .94 1.01 1.01 1.02 .94 .99
ATP 1.06 .97 .99 .95 1.02 .99 .98
KLA/ATP 1.03 1.07 .99 1.07 .94 .99 1.00
Sst
KLA  ATP  ATP+KLA
 NM_009215 somatostatin (Sst), mRNA [NM_009215] KLA 1.07 1.09 1.12 1.14 1.11 1.12 1.11
ATP .99 .96 1.00 1.00 1.01 .99 1.03
KLA/ATP 1.08 1.04 1.13 1.04 1.07 1.07 1.10
Sstr1
KLA  ATP  ATP+KLA
 NM_009216 somatostatin receptor 1 (Sstr1), mRNA [NM_009216] KLA .96 1.06 .98 1.03 .97 .95 .98
ATP .96 .99 1.04 .99 .97 .93 1.03
KLA/ATP .97 1.01 .99 1.03 .92 .94 1.09
Sstr3
KLA  ATP  ATP+KLA
 NM_009218 somatostatin receptor 3 (Sstr3), mRNA [NM_009218] KLA 1.00 1.07 1.03 1.01 1.04 .99 1.01
ATP .99 .95 .98 1.06 .99 1.00 .98
KLA/ATP 1.06 .96 1.00 .92 .97 1.08 .99
Sstr4
KLA  ATP  ATP+KLA
 AK158660 visual cortex cDNA, RIKEN full-length enriched library, clone:K230047D01 product:unclassifiable, full insert sequence [AK158660] KLA .98 .98 1.01 1.00 1.03 1.09 1.02
ATP .99 1.03 .98 1.05 .96 1.09 .99
KLA/ATP 1.02 1.01 .96 1.00 1.07 1.04 .98
Sstr4
KLA  ATP  ATP+KLA
 NM_009219 somatostatin receptor 4 (Sstr4), mRNA [NM_009219] KLA 1.05 1.08 1.18 1.25 1.15 1.20 1.14
ATP 1.06 .99 1.19 1.31 1.31 1.14 1.06
KLA/ATP 1.15 1.19 1.46 1.29 1.27 1.27 1.17
Taar1
KLA  ATP  ATP+KLA
 NM_053205 trace amine-associated receptor 1 (Taar1), mRNA [NM_053205] KLA 1.00 1.06 .96 1.05 1.01 .92 1.04
ATP 1.09 .89 .98 1.01 .96 .96 .95
KLA/ATP 1.05 1.02 1.08 .98 .91 .94 1.07
Taar2
KLA  ATP  ATP+KLA
 NM_001007266 trace amine-associated receptor 2 (Taar2), mRNA [NM_001007266] KLA .91 .98 1.00 .96 .97 1.07 1.04
ATP 1.01 .95 .99 .92 .97 1.02 1.04
KLA/ATP 1.13 .95 .98 .86 .99 1.00 1.00
Taar4
KLA  ATP  ATP+KLA
 NM_001008499 trace amine-associated receptor 4 (Taar4), mRNA [NM_001008499] KLA 1.03 .99 1.08 1.11 1.04 1.00 1.12
ATP .98 .95 .98 1.04 .98 1.10 1.07
KLA/ATP 1.03 1.09 1.11 1.07 .97 1.04 1.13
Taar9
KLA  ATP  ATP+KLA
 NM_001010831 trace amine-associated receptor 9 (Taar9), mRNA [NM_001010831] KLA 1.05 1.09 1.08 1.13 1.15 1.12 1.04
ATP 1.01 1.04 1.03 1.07 1.07 1.15 1.06
KLA/ATP 1.23 1.10 1.12 1.04 1.04 1.07 1.05
Tac1
KLA  ATP  ATP+KLA
 AK015286 adult male testis cDNA, RIKEN full-length enriched library, clone:4930432H04 product:tachykinin 1, full insert sequence [AK015286] KLA .98 1.08 1.00 .93 1.07 1.07 1.05
ATP 1.02 1.00 .97 1.07 1.00 1.10 1.01
KLA/ATP 1.05 1.01 .96 1.04 .98 1.12 1.03
Tac1
KLA  ATP  ATP+KLA
 NM_009311 tachykinin 1 (Tac1), mRNA [NM_009311] KLA .99 1.03 1.07 1.03 1.02 1.10 1.18
ATP 1.00 1.01 1.05 1.10 1.02 1.06 1.08
KLA/ATP 1.06 .96 1.01 1.13 1.13 1.08 .97
Tac2
KLA  ATP  ATP+KLA
 D14423 PPT-B mRNA for preprotachykinin B, complete cds [D14423] KLA 1.21 1.22 1.16 1.20 1.10 1.12 1.12
ATP .99 1.00 1.09 1.09 1.13 1.11 .96
KLA/ATP 1.12 1.29 1.30 1.31 1.21 1.13 .97
Tac4
KLA  ATP  ATP+KLA
 NM_053093 tachykinin 4 (Tac4), mRNA [NM_053093] KLA .91 .95 .98 .98 .95 1.02 .94
ATP 1.01 .96 .92 .98 .98 .99 .96
KLA/ATP .94 .94 .97 1.04 .92 .96 .98
Tacr1
KLA  ATP  ATP+KLA
 NM_009313 tachykinin receptor 1 (Tacr1), mRNA [NM_009313] KLA 1.21 1.16 1.23 1.08 1.14 1.12 1.06
ATP 1.05 1.03 1.06 1.01 1.00 1.02 1.09
KLA/ATP 1.16 1.23 1.06 1.22 1.10 1.07 1.08
Tacr2
KLA  ATP  ATP+KLA
 NM_009314 tachykinin receptor 2 (Tacr2), mRNA [NM_009314] KLA 1.04 1.13 1.11 1.14 1.12 1.11 1.06
ATP 1.02 1.00 1.01 1.03 1.05 1.10 1.01
KLA/ATP 1.05 1.10 1.17 1.17 1.06 1.01 1.03
Tacr3
KLA  ATP  ATP+KLA
 NM_021382 tachykinin receptor 3 (Tacr3), mRNA [NM_021382] KLA .97 .98 1.07 1.00 1.01 1.02 .92
ATP 1.01 .99 .99 1.01 1.02 1.01 1.05
KLA/ATP 1.03 1.00 1.02 1.01 .94 1.01 1.00
Tbxa2r
KLA  ATP  ATP+KLA
 NM_009325 thromboxane A2 receptor (Tbxa2r), mRNA [NM_009325] KLA 1.02 1.02 1.03 1.01 1.01 1.02 1.05
ATP .97 .98 1.03 1.09 1.06 1.09 1.01
KLA/ATP 1.00 1.05 1.02 1.04 1.09 1.14 1.12
Thra
KLA  ATP  ATP+KLA
 NM_178060 thyroid hormone receptor alpha (Thra), mRNA [NM_178060] KLA .55 .54 .56 .60 .79 .88 .82
ATP 1.05 .92 .81 .73 1.60 1.17 .99
KLA/ATP .53 .53 .54 .64 3.05 1.91 1.34
Thrb
KLA  ATP  ATP+KLA
 NM_009380 thyroid hormone receptor beta (Thrb), transcript variant 2, mRNA [NM_009380] KLA .99 .97 1.00 1.00 .98 1.03 1.01
ATP .99 1.02 1.01 .99 .99 .96 1.03
KLA/ATP .97 1.00 .97 1.03 1.01 .96 1.01
Trh
KLA  ATP  ATP+KLA
 NM_009426 thyrotropin releasing hormone (Trh), mRNA [NM_009426] KLA 1.07 1.04 1.05 .97 1.03 .95 .98
ATP .94 1.09 1.01 .97 .96 1.08 .96
KLA/ATP .92 .99 1.08 .98 1.00 1.02 .94
Trhr
KLA  ATP  ATP+KLA
 NM_013696 thyrotropin releasing hormone receptor (Trhr), mRNA [NM_013696] KLA 1.02 1.02 1.03 1.02 .97 .96 .95
ATP 1.07 .94 .98 1.01 .99 .99 .96
KLA/ATP 1.02 .99 .99 1.00 .99 .94 .94
Trhr2
KLA  ATP  ATP+KLA
 NM_133202 thyrotropin releasing hormone receptor 2 (Trhr2), mRNA [NM_133202] KLA .99 1.01 1.00 1.02 .98 1.07 1.08
ATP .96 1.02 1.01 1.02 .95 .97 .98
KLA/ATP 1.01 .96 1.00 1.04 .97 1.00 .97
Tshb
KLA  ATP  ATP+KLA
 AK036251 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630048K15 product:thyroid stimulating hormone, beta subunit, full insert sequence [AK036251] KLA .98 .97 .97 1.05 .92 .98 1.00
ATP .99 .92 .96 1.02 1.01 1.02 .97
KLA/ATP .99 .98 1.03 .99 .96 1.00 1.03
Tshb
KLA  ATP  ATP+KLA
 NM_009432 thyroid stimulating hormone, beta subunit (Tshb), mRNA [NM_009432] KLA 1.00 1.06 1.07 1.05 .98 1.03 .99
ATP 1.03 1.01 1.01 .93 1.01 .97 1.00
KLA/ATP 1.00 1.01 .98 .95 1.01 1.08 .95
Tshr
KLA  ATP  ATP+KLA
 NM_011648 thyroid stimulating hormone receptor (Tshr), transcript variant 1, mRNA [NM_011648] KLA 1.01 .99 1.02 1.01 1.00 1.01 .97
ATP 1.05 1.01 1.01 .97 .99 .99 1.05
KLA/ATP .97 1.05 1.02 .95 .97 .93 .99
Tspo
KLA  ATP  ATP+KLA
 NM_009775 translocator protein (Tspo), mRNA [NM_009775] KLA 2.43 2.59 2.88 3.03 4.05 4.37 4.80
ATP 1.15 1.16 .97 1.30 1.13 1.25 2.08
KLA/ATP 2.72 2.79 2.51 3.45 2.78 3.22 5.46
Ucn2
KLA  ATP  ATP+KLA
 AF331517 urocortin II mRNA, complete cds [AF331517] KLA 1.04 .99 1.03 1.00 1.01 1.04 .98
ATP 1.04 1.13 1.01 1.11 1.06 1.10 1.01
KLA/ATP 1.01 .97 1.05 1.13 1.08 .91 1.07
Ucn3
KLA  ATP  ATP+KLA
 NM_031250 urocortin 3 (Ucn3), mRNA [NM_031250] KLA .99 .92 1.06 .98 .97 1.01 1.00
ATP .98 1.04 1.00 1.05 .99 .99 .93
KLA/ATP 1.10 1.04 1.03 1.00 1.01 1.03 .99
Uts2
KLA  ATP  ATP+KLA
 NM_011910 urotensin 2 (Uts2), mRNA [NM_011910] KLA 1.01 1.08 1.07 .97 .97 1.00 1.13
ATP .98 .99 1.02 1.02 .96 1.01 1.00
KLA/ATP .99 .96 1.03 1.04 .95 .97 .99
Uts2r
KLA  ATP  ATP+KLA
 NM_145440 urotensin 2 receptor (Uts2r), mRNA [NM_145440] KLA 1.19 1.22 1.18 1.33 1.24 1.15 1.06
ATP 1.06 1.19 1.74 2.18 1.33 .97 1.03
KLA/ATP 1.19 1.28 1.88 2.05 1.49 1.12 1.20
Vip
KLA  ATP  ATP+KLA
 NM_011702 vasoactive intestinal polypeptide (Vip), mRNA [NM_011702] KLA 1.02 .93 .96 1.07 1.01 1.01 1.03
ATP .99 .98 .99 1.00 1.05 .99 1.02
KLA/ATP 1.11 .98 .94 1.03 1.01 .99 .98
Vipr1
KLA  ATP  ATP+KLA
 NM_011703 vasoactive intestinal peptide receptor 1 (Vipr1), mRNA [NM_011703] KLA 1.00 1.03 1.06 1.03 .99 1.00 .88
ATP 1.03 .95 1.12 1.03 .98 1.02 .89
KLA/ATP .99 1.04 1.09 1.04 1.00 .96 .85
Vipr2
KLA  ATP  ATP+KLA
 AK038743 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230059F17 product:vasoactive intestinal peptide receptor 2, full insert sequence. [AK038743] KLA 1.01 1.03 1.00 .95 1.08 1.08 .97
ATP .99 1.01 .98 .95 1.03 .98 .96
KLA/ATP 1.03 1.05 1.03 1.03 1.01 1.07 1.05
Vipr2
KLA  ATP  ATP+KLA
 NM_009511 vasoactive intestinal peptide receptor 2 (Vipr2), mRNA [NM_009511] KLA 1.02 .98 1.05 .99 1.01 1.06 1.05
ATP .96 .99 1.03 1.04 1.02 1.07 .92
KLA/ATP 1.07 1.04 .97 1.10 1.02 1.13 1.02